Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,double-stranded RNA binding (GO:0003725),0.7061382161606047,2.054969501464271,0.0,0.0010228970142116215,0.001,18/70,5.02%,DDX60;OAS3;ZBP1;OASL;EIF2AK2;OAS2;IFIH1;DHX58;ACTN1;ADAR;DHX33;AGO2;ZFR2;TARBP2;ILF3;DHX36;HSP90AB1;TLR8
prerank,adenylyltransferase activity (GO:0070566),0.7933475125318188,1.965691688930476,0.0,0.006137382085269729,0.011,4/21,0.82%,OAS3;OASL;OAS2;TENT4A
prerank,CXCR chemokine receptor binding (GO:0045236),0.8535860962009952,1.8847693664895406,0.0,0.03955201788284937,0.09,2/11,0.33%,CXCL10;CXCL9
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.7390474363820746,1.876044571985671,0.0012755102040816326,0.03452277422964222,0.103,6/25,4.18%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,glutamate receptor binding (GO:0035254),-0.6179756808574383,-1.8592015585233892,0.0,0.41264784037590113,0.337,10/17,22.37%,DLG4;HOMER1;HOMER3;SHISA6;SHANK3;NSF;GNAS;SHISA7;CAMK2A;SHANK1
prerank,pentosyltransferase activity (GO:0016763),0.6769397356019828,1.844492009047284,0.001201923076923077,0.04725784205657692,0.176,6/36,4.18%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,chemokine activity (GO:0008009),0.7041171379749693,1.8405844947922323,0.0,0.04159781191127261,0.187,6/31,5.24%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,CARD domain binding (GO:0050700),0.8069883854452755,1.8123099588353357,0.0,0.06166607714247204,0.304,4/14,1.44%,IRGM;CASP4;NOD2;NOD1
prerank,single-stranded RNA binding (GO:0003727),0.6564868260070187,1.806262055615659,0.0011904761904761906,0.060095199584932764,0.326,14/43,12.66%,DDX60;IFIH1;DHX58;POLR2G;AGO2;ZFR2;ILF3;TLR8;SRA1;DHX9;EIF4H;LONP1;HNRNPA1;DDX11
prerank,channel activity (GO:0015267),0.6424729997621544,1.7677894128862897,0.0,0.101835080525957,0.531,11/41,12.88%,TRPM5;AQP11;PANX2;ASIC4;AQP4;TMEM120B;PDPN;TMEM266;PANX1;KCNK3;TRPV4
prerank,chemokine receptor binding (GO:0042379),0.658130095548398,1.7621444079103141,0.0,0.09922101037852729,0.56,6/35,5.24%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,water transmembrane transporter activity (GO:0005372),0.8190643686554024,1.7567091846901488,0.004310344827586207,0.09875605719024927,0.599,3/11,9.06%,AQP11;AQP4;PDPN
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6560165457098773,-1.6658256037389843,0.002976190476190476,1.0,0.891,8/10,27.29%,DLG4;SHISA6;SHANK3;NSF;GNAS;SHISA7;SHANK1;IGSF11
prerank,cytokine activity (GO:0005125),0.5375389886459859,1.661174533053084,0.0,0.3413918784931287,0.964,17/131,11.13%,CXCL10;CXCL9;WNT11;IL15;CRLF1;CCL7;WNT5A;GDF9;CXCL16;KITLG;CCL5;CX3CL1;WNT7B;CSF1;HMGB1;IL17D;CCL14
prerank,ubiquitin binding (GO:0043130),0.559114719717729,1.6532735262854532,0.0,0.3448736625607336,0.975,30/73,16.27%,UBE2L6;ILRUN;CXCR4;AUP1;BIRC2;UBAP1;FBXO7;RBCK1;USP25;RNFT1;MVB12A;FBXW7;UBXN1;GGA3;NBR1;N4BP1;RAE1;UCHL3;RNF31;RNF19B;UBXN2B;UBXN11;FAF2;VPS28;RNF185;USPL1;SHARPIN;ASCC2;SPRTN;OTULINL
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7499715984498957,1.6358120750044611,0.011940298507462687,0.39060053128395206,0.988,1/11,0.46%,CNGB1
prerank,ATP hydrolysis activity (GO:0140603),0.5896234424744353,1.6319880391022712,0.004739336492890996,0.3797675648096347,0.993,8/41,9.50%,RNF213;HSPA1B;TOR3A;CLU;KIF26A;CHD1L;DHX9;ABCD1
prerank,peptidoglycan binding (GO:0042834),0.7617174511013902,1.6188928286410118,0.01804511278195489,0.4083916329239899,0.998,5/10,15.56%,NOD2;NOD1;RNASE7;HK1;TLR2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5467307504960662,-1.5941706822662394,0.026515151515151516,1.0,0.981,5/15,9.92%,CYB5A;COX15;COX10;NDUFA4;COX8A
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.7105398304416924,1.5935014305673618,0.020891364902506964,0.5040475463559266,0.999,3/14,5.74%,RSAD2;EXO5;NFU1
prerank,receptor antagonist activity (GO:0048019),0.6672420665229967,1.5832738738284724,0.02571041948579161,0.5231549951573438,0.999,4/17,10.76%,ESR2;CCL5;LRPAP1;DKK3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6724084534060493,1.5759832399307503,0.026954177897574125,0.5310988971156655,0.999,2/16,2.11%,BCO2;ETHE1
prerank,semaphorin receptor activity (GO:0017154),0.7198807561038882,1.5546140324821145,0.030434782608695653,0.6203358942686379,1.0,4/11,4.62%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.701064216492152,1.5490520924350548,0.03483309143686502,0.6218239658774076,1.0,5/12,8.58%,CANT1;ENTPD3;ENTPD6;NUDT5;ENTPD5
prerank,regulatory RNA binding (GO:0061980),0.5710904499791165,1.5458659407856326,0.015439429928741092,0.6106695174843381,1.0,13/38,16.76%,PNPT1;ZC3H7A;AGO2;TARBP2;DHX9;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7;DICER1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.709703922271067,1.5358470467183292,0.045112781954887216,0.6394440552319431,1.0,3/10,9.85%,CXCL10;PRKAR2B;PRKAG1
prerank,alpha-actinin binding (GO:0051393),-0.4638500479568491,-1.532361922675278,0.05150214592274678,1.0,0.996,7/24,14.59%,PDLIM5;PPARG;LDB3;RARA;PDLIM1;PKD2L1;PDLIM7
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7059654996837676,1.5144462142151733,0.036127167630057806,0.7333745384808072,1.0,3/11,6.23%,THAP7;MBD2;ZXDC
prerank,miRNA binding (GO:0035198),0.5763782895049974,1.5054156950096445,0.04567901234567901,0.7590305004255916,1.0,10/30,16.28%,PNPT1;ZC3H7A;AGO2;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.583279590838869,-1.5022140643673902,0.05362776025236593,1.0,0.997,5/11,21.11%,KCND2;KCND1;KCND3;KCNT2;KCNT1
prerank,ribosomal small subunit binding (GO:0043024),0.6396971437460321,1.5005846631217328,0.04246575342465753,0.7603665612949234,1.0,11/17,20.49%,ERAL1;LARP1;MTIF3;ABCE1;EIF4H;NPM1;PIM1;EIF1B;CPEB2;EIF4B;DDX3X
prerank,hexosaminidase activity (GO:0015929),0.6662774025052094,1.4804251106393571,0.06259097525473072,0.8620748725327945,1.0,4/12,8.22%,HYAL1;SPAM1;HYAL4;HEXD
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5370707514596019,-1.4720603721049688,0.059190031152647975,1.0,0.998,11/13,46.33%,BMP6;SRC;BMP3;BMP5;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,chemoattractant activity (GO:0042056),0.57691718938454,1.4704823715184323,0.04868913857677903,0.8977382581155853,1.0,6/26,11.23%,CXCL10;CCL5;CX3CL1;GDNF;HMGB1;VEGFD
prerank,MHC protein binding (GO:0042287),0.5964921391271127,1.466716346506261,0.061855670103092786,0.8923541918117177,1.0,5/20,12.74%,FCRL6;LAG3;TAPBP;ABCB9;TUBB4B
prerank,calcium activated cation channel activity (GO:0005227),0.6198084758466735,1.4611532424520288,0.06693989071038252,0.902092876833229,1.0,2/17,0.74%,TRPM5;KCNMB3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.516577288093203,-1.4575504729351634,0.07011070110701106,1.0,0.999,5/15,15.67%,CCR5;CX3CR1;CCR2;CMKLR1;CCR1
prerank,mRNA 5'-UTR binding (GO:0048027),0.590925114239646,1.4566020794569023,0.05949367088607595,0.9035810270055176,1.0,5/24,4.84%,IGF2BP1;IGF2BP3;LARP1;RSL1D1;DHX36
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6757262604373816,1.4462333863708625,0.05635838150289017,0.9436224956102208,1.0,4/11,6.10%,CASP4;CASP7;CASP6;CFLAR
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4503687757239824,1.4376845747407334,0.0,0.9733020074619672,1.0,57/269,12.73%,STAT1;STAT2;HSPA1B;PARP9;ISG15;PML;UBE2L6;DTX3L;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;UBE2W;TPI1;DDRGK1;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;SUMO3;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;PRR7;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;RB1;UBE2L3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5040252052239601,1.4331722007545133,0.05411499436302142,0.9741589800050677,1.0,11/53,9.66%,MTHFR;ACOXL;XDH;CYB5R2;GFER;CYBB;ACADL;CYB5R3;LDHD;DLD;GSR
prerank,BMP receptor binding (GO:0070700),-0.5370998116760828,-1.4319512588489314,0.08923076923076922,1.0,0.999,11/12,46.33%,BMP6;SRC;BMP3;BMP5;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,microtubule minus-end binding (GO:0051011),-0.5220578243225278,-1.4287720166725049,0.07894736842105263,1.0,0.999,6/13,11.86%,MACF1;TUBGCP3;TUBGCP4;TUBGCP6;HAUS4;TUBGCP2
prerank,sodium channel regulator activity (GO:0017080),0.52556008855558,1.4284474090535715,0.05875440658049354,0.97824025313404,1.0,9/37,16.23%,SGK2;SGK3;CAMK2D;FXYD4;FXYD6;RSC1A1;FXYD5;FGF13;SCN1B
prerank,N-acetyltransferase activity (GO:0008080),0.5941920777490428,1.4254142406921644,0.06701708278580815,0.9709565769344315,1.0,4/19,6.26%,SATL1;SAT1;NAA50;SMARCE1
prerank,protein kinase regulator activity (GO:0019887),0.4710305611987436,1.423624323004609,0.02198952879581152,0.9566298752098576,1.0,24/95,13.93%,CXCL10;WNT11;TAOK3;SOCS1;DAXX;CCNL1;CCNJ;CCND2;CCNL2;CCND1;CCNT2;CAB39;MT3;CSNK2B;CNPPD1;GMFB;AGAP2;PRKAR2B;NCK1;PRKAG1;NPM1;FGF13;CCNI;DUS2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6585757893114573,1.422936281838245,0.07600596125186289,0.9357892579487581,1.0,1/11,0.32%,CHRNA9
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6842702426863225,1.4206764472834708,0.05365126676602087,0.9262725885614775,1.0,4/10,6.10%,CASP4;CASP7;CASP6;CFLAR
prerank,SUMO binding (GO:0032183),0.6459900799776845,1.4204588967599405,0.09337349397590361,0.9045989745180475,1.0,8/13,15.64%,PML;RNF4;USP25;HERC2;UBA2;CBX4;USPL1;TDG
prerank,ligand-gated calcium channel activity (GO:0099604),0.5961461418065466,1.415934121175455,0.08412483039348712,0.910403291356007,1.0,5/19,9.00%,TRPM5;TRPM2;GRIN2D;ITPR1;P2RX4
prerank,muscle alpha-actinin binding (GO:0051371),-0.48616979630031487,-1.4131616430794205,0.08163265306122448,1.0,1.0,5/15,14.59%,PDLIM5;LDB3;PDLIM1;PKD2L1;PDLIM7
prerank,P-type ion transporter activity (GO:0015662),-0.5377367662245941,-1.4114216305668057,0.09859154929577464,1.0,1.0,6/12,27.41%,ATP6V1E1;ATP2A2;ATP2C1;ATP2A3;ATP2B2;ATP2B4
prerank,four-way junction DNA binding (GO:0000400),0.5958466121632887,1.4090200409991005,0.09811827956989247,0.9310798298407212,1.0,7/17,15.02%,MSH2;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6326947858766906,1.4075834922981305,0.08645533141210375,0.9178954462876657,1.0,6/12,18.99%,SPPL2A;PSEN1;NAPSA;SPPL3;HM13;DDI2
prerank,methyl-CpG binding (GO:0008327),0.5598797734094602,1.406293947115366,0.08964646464646464,0.9046594184325236,1.0,11/22,17.78%,LRWD1;MECP2;MBD2;ZBTB38;CXXC4;CHTOP;ZBTB21;ZCWPW1;PRMT1;ZBTB4;CXXC5
prerank,thyroid hormone receptor binding (GO:0046966),0.5417735863608839,1.405354696378823,0.0922882427307206,0.8901931749012338,1.0,3/28,2.03%,OASL;HMGN3;PRMT2
prerank,mRNA 3'-UTR binding (GO:0003730),0.48629885229988173,1.405205225598278,0.02267818574514039,0.871775098807661,1.0,21/79,17.13%,IGF2BP1;ZFP36;IGF2BP3;TARDBP;RNF40;DDX5;LARP1;RSL1D1;ILF3;DHX36;AUH;RBMS2;HNRNPA2B1;ZC3H12A;RNPS1;ZFP36L1;SECISBP2;EXOSC9;DAZAP1;MEX3D;PCBP4
prerank,ion channel inhibitor activity (GO:0008200),0.5217696190159525,1.3990492230057725,0.07938388625592417,0.8879834271669866,1.0,14/35,24.97%,CAMK2D;ITPR1;SLC30A1;STX7;STX8;RSC1A1;RACK1;VTI1B;SCN1B;ENSA;CALM2;WNK3;CFTR;COMMD1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.47690953953017856,1.3967165627447686,0.03344120819848975,0.8829732268092568,1.0,24/74,14.69%,ETNK1;GLYCTK;PIK3CD;TRPT1;HYKK;FCSK;PGM2L1;NOL9;IDNK;NT5C3A;FAM20B;NADK;NMRK1;PI4KB;HK1;DGKB;SPHK2;DGKK;FGGY;GNE;PIK3CB;GALK2;FAM20C;PANK2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.527412924032914,1.3921706595501049,0.07787391841779975,0.8912564311173669,1.0,8/29,14.86%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;SLC26A2;SLC25A12
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5213271557394322,1.388747169358381,0.06934306569343066,0.8947689342114736,1.0,13/34,21.52%,IRGM;SPRY2;ETAA1;CCNT2;CAB39;MTCP1;MAP2K2;CALM3;CCNK;CAB39L;STK3;DDX3X;CKS2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6515918899200746,1.387502479148871,0.11585365853658537,0.8840638155376441,1.0,2/11,4.68%,TRPM2;ITPR1
prerank,disordered domain specific binding (GO:0097718),0.549059492700783,1.3859246211632572,0.09536423841059603,0.8755408308758665,1.0,10/23,24.61%,TEAD2;HSP90AB1;SMAD2;RB1;FYN;HSP90AA1;CALM3;NUMA1;BCL2L2;CALM2
prerank,cGMP binding (GO:0030553),0.630884674586718,1.3857685635219528,0.10944527736131934,0.8598510901350219,1.0,2/11,8.09%,CNGB1;RAPGEF2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6386903634779901,1.383215041413487,0.09425625920471281,0.8584379053711532,1.0,4/12,11.40%,STAT1;TRAF4;TRAF3;TRAF5
prerank,nucleotidyltransferase activity (GO:0016779),0.5705546040338533,1.377508073454194,0.09103078982597054,0.8737028351569737,1.0,7/19,16.28%,TENT4A;PNPT1;CGAS;MOCS3;NUDT5;CRPPA;TUT7
prerank,sequence-specific mRNA binding (GO:1990825),0.6512451555909345,1.3769674081617538,0.10588235294117647,0.8607861034771904,1.0,3/10,15.37%,DHFR;DHX9;ETF1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6419608683015892,1.3724248911716834,0.1274658573596358,0.8692291697783915,1.0,2/10,1.78%,PML;DAXX
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5762826890182298,1.3704677998374888,0.10742705570291777,0.8637483477246272,1.0,8/18,20.79%,SOCS1;AGAP2;SOCS5;SOCS2;SOCS6;WDR91;SOCS4;SOCS7
prerank,chemorepellent activity (GO:0045499),-0.40575698483896105,-1.3703703017567934,0.06315789473684211,1.0,1.0,16/25,28.97%,SEMA4C;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;DPP4;SEMA3E;SEMA5B;SEMA6D;SEMA4F;NRG3;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,5'-3' exonuclease activity (GO:0008409),0.5887072085702605,1.3667978615483518,0.13031161473087818,0.8685782629658988,1.0,7/14,19.73%,XRN2;XRN1;DCP2;FEN1;DCLRE1A;TRIR;DCLRE1C
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4725554620687143,1.3661034170121065,0.07317073170731707,0.8577843878342957,1.0,12/60,9.32%,AXL;FLT1;KDR;ACVR1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;ROR2;INSR
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5743220866030743,1.3647201405334628,0.1125,0.8509497030029991,1.0,4/17,5.48%,ATP10A;ABCA1;ABCG1;PITPNM1
prerank,cysteine-type peptidase activity (GO:0008234),0.46061676361476894,1.3642618257839552,0.056623931623931624,0.8397324553119857,1.0,13/73,8.92%,USP18;CASP4;CASP7;CTSS;USP50;USP25;CASP6;USP21;USP15;USP40;CTSC;CTSH;USP34
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.47041349132015275,1.3619526175916674,0.06637168141592921,0.8392626454698209,1.0,12/60,9.32%,AXL;FLT1;KDR;NRP2;EPHA4;FGFR2;RET;EPHA6;LTK;MET;ROR2;INSR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.50447573515826,1.360317897159633,0.08924205378973105,0.8354191708256478,1.0,9/35,12.87%,STAT1;ZBTB17;AGO2;UBTF;TBPL1;NPM1;KLF10;NR3C1;TAF1B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6184433292853572,1.3591201289861217,0.1037037037037037,0.8287511609142557,1.0,4/12,13.17%,TENT4A;TENT5A;PAPOLA;TENT5C
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.5842190673236287,1.3584334912530336,0.13179347826086957,0.819464495900383,1.0,4/15,9.82%,RBBP5;KMT2A;SETD3;WDR5
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6519855441524188,1.3580691385110228,0.121875,0.8087909287294756,1.0,4/10,10.77%,NSD3;SETD3;ASH1L;SETD5
prerank,CoA-ligase activity (GO:0016405),-0.48576826619843216,-1.3507762209554424,0.1167192429022082,1.0,1.0,6/14,21.71%,ACSS3;AACS;ACSL1;ACSS1;ACSBG1;SLC27A2
prerank,O-methyltransferase activity (GO:0008171),0.6407609914214858,1.3499633654840624,0.13497822931785197,0.8368350558471577,1.0,4/10,14.96%,BCDIN3D;MEPCE;COQ3;COMT
prerank,RNA methyltransferase activity (GO:0008173),0.5682188096220301,1.3479671474721155,0.12631578947368421,0.8345950160302301,1.0,6/19,9.70%,TRMT9B;BCDIN3D;MRM2;MEPCE;TRMT13;TGS1
prerank,RNA cap binding (GO:0000339),0.5725800201228265,1.3478071808482994,0.13161465400271372,0.8234759348838216,1.0,7/16,19.57%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS;SNUPN
prerank,MHC class I protein binding (GO:0042288),0.6010433312642636,1.338842280997199,0.1312410841654779,0.8564961618997311,1.0,8/13,29.55%,TAPBP;ABCB9;TUBB4B;TAP1;ATP5F1B;PILRA;TUBB;LILRB1
prerank,kinase activator activity (GO:0019209),0.5208238812221595,1.33860138885365,0.11,0.845665899596483,1.0,7/30,13.09%,WNT11;DAXX;CAB39;MT3;AGAP2;MOB1B;FGF13
prerank,receptor ligand activity (GO:0048018),0.422973310953086,1.3360980425253164,0.012012012012012012,0.8461320027831337,1.0,27/245,11.35%,CXCL10;CXCL9;WNT11;IL15;AGT;CRLF1;WNT5A;BDNF;GDF9;SEMA4D;KITLG;TGFA;SFRP2;CCL5;TAFA4;OSGIN1;CX3CL1;WNT7B;CSF1;NPPC;GDNF;HMGB1;LRPAP1;TAFA2;IL17D;VEGFD;FGF9
prerank,neurexin family protein binding (GO:0042043),-0.5307361658087092,-1.335130087213728,0.13218390804597702,1.0,1.0,4/10,15.04%,SYTL2;NLGN2;SYTL5;CPE
prerank,protein kinase activator activity (GO:0030295),0.46141348714682695,1.3341103439797,0.08852459016393442,0.8441526724444528,1.0,18/60,22.82%,WNT11;IRGM;SPRY2;DAXX;ETAA1;CAB39;MT3;AGAP2;MTCP1;MAP2K2;FGF13;CALM3;CAB39L;STK3;DDX3X;STK11;ERBB3;GPRC5B
prerank,histone methyltransferase binding (GO:1990226),0.61820736884097,1.3328283912702998,0.15,0.8391165173249334,1.0,5/11,12.79%,HSP90AB1;CTNNB1;LCORL;LCOR;PRDM4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4223726931563255,1.3317771946127535,0.025252525252525252,0.8331361589041261,1.0,44/181,17.28%,STAT1;PARP9;PITX2;TAF4B;DTX3L;DDRGK1;STAT3;RBL1;MTA3;MAD2L2;BHLHE40;NCOA1;CTNNB1;ARID1A;TCF7L2;SMARCE1;DHX9;TACC2;MDFIC;MTA2;DACT1;LMO2;MAPK14;PROX1;COMMD7;DUSP26;NPM1;SNW1;LDB2;LDB1;PPARGC1A;RB1;MIER1;BUD31;RNF25;ACTB;BBS2;PIAS1;MEF2A;PPARD;PIAS2;RBPJ;TRIP4;ANXA4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5922350208265492,1.33113116984108,0.14223512336719885,0.8255708811064342,1.0,2/12,7.67%,STAT1;TBPL1
prerank,frizzled binding (GO:0005109),0.48859332745101985,1.326366382673185,0.13510253317249699,0.8378706812178809,1.0,5/34,8.55%,WNT11;WNT5A;WNT7B;MYOC;BAMBI
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5762384358049024,1.3238678150524423,0.15134370579915135,0.83965601996956,1.0,5/14,17.59%,MTHFR;DHFR;AASS;BLVRB;MTHFD1
prerank,transferrin receptor binding (GO:1990459),-0.5343437223814979,-1.3238042256902085,0.13230769230769232,1.0,1.0,3/10,7.63%,CD81;SNX4;IKBKG
prerank,cysteine-type endopeptidase activity (GO:0004197),0.44676159096673135,1.3235913682989664,0.08369098712446352,0.8303238650736061,1.0,16/78,13.10%,USP18;CASP4;CASP7;CTSS;GPAA1;USP25;CASP6;USP15;USP40;CFLAR;CTSC;CTSH;USP34;USP14;CAPNS1;CAPN1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4797657800416206,1.3211416372819629,0.13262910798122066,0.8316152725540483,1.0,4/38,9.16%,AGT;SERPINC1;SLPI;APP
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.4292030575703959,-1.319876650045642,0.1037037037037037,1.0,1.0,3/17,2.84%,BLVRA;TECR;LBR
prerank,calcium-activated potassium channel activity (GO:0015269),0.6101686158998924,1.3187001562798024,0.14479638009049775,0.832713015691251,1.0,1/11,0.74%,KCNMB3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5523276812560357,1.3180136458249698,0.1702127659574468,0.8259215566436174,1.0,5/18,15.92%,NOL3;BIRC2;MT3;BIRC3;CD27
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.504901665032514,1.3161056887989,0.1453416149068323,0.824454993454567,1.0,6/28,11.40%,STAT1;TNFSF9;FEM1B;TRAF4;TRAF3;TRAF5
prerank,glycine binding (GO:0016594),-0.5138032470241557,-1.313152037111863,0.16233766233766234,1.0,1.0,5/11,11.77%,GRIN2B;SRR;GRIN1;GLRB;GLRA3
prerank,leucine zipper domain binding (GO:0043522),0.6149540284755576,1.3111593739068694,0.15160349854227406,0.8372833254210328,1.0,2/10,7.87%,DAPK3;MRTFA
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5955621575736483,1.3072869823664082,0.1825962910128388,0.8453768056405929,1.0,6/12,17.91%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS
prerank,ADP binding (GO:0043531),0.514206783308208,1.3072677317403005,0.13392857142857142,0.8357656477956195,1.0,11/25,19.70%,MSH2;ABCG1;ABCD1;PRKAG1;LONP1;MYO6;GLUD1;GCLC;MYH9;TAP1;ERN1
prerank,filamin binding (GO:0031005),-0.5252950952594326,-1.3055227959147024,0.1557632398753894,1.0,1.0,5/11,13.53%,DPYSL3;FBLIM1;NEBL;CRMP1;CEACAM1
prerank,histone deacetylase binding (GO:0042826),0.4331590819154961,1.3028695272278144,0.09371671991480299,0.8467959941513253,1.0,34/88,24.51%,HSPA1B;THAP7;MEF2B;MTA3;PKN2;NACC1;DHX36;HSP90AB1;CCND1;USF1;MTA2;DACT1;SMG5;LCOR;MIER1;ZMYND15;HSP90AA1;CAMTA2;MEF2A;HDAC1;BCOR;ANKRA2;GLI3;PRDM1;HDAC2;RAD9A;NACC2;KCTD21;HDAC4;NCOR2;HDAC6;KAT2B;TFAP4;YWHAE
prerank,NAD binding (GO:0051287),0.5127604423371204,1.3027955688350055,0.15679012345679014,0.8375917494910151,1.0,4/26,1.99%,PARP9;ZC3HAV1;SORD;GRHPR
prerank,kinase activity (GO:0016301),0.4287543266582713,1.3009411201262866,0.08004158004158005,0.8367297576251064,1.0,30/109,16.86%,PKMYT1;ETNK1;GLYCTK;TRIB3;PIK3CD;ITPKC;HYKK;FCSK;PKN2;PGM2L1;EPHA4;IDNK;PPIP5K1;SEPHS1;LYN;NADK;NMRK1;PI4KB;DGKB;CERKL;SPHK2;DGKK;BCKDK;PIK3CB;PANK2;MASTL;MTOR;IRAK1;STK39;DGKA
prerank,DNA polymerase binding (GO:0070182),0.5465790144498053,1.296863573545735,0.1628838451268358,0.8458009432346534,1.0,8/18,17.31%,HSP90AB1;POLG2;CDT1;RTEL1;HMGB1;LONP1;HSP90AA1;PTGES3
prerank,lipoprotein particle receptor binding (GO:0070325),0.5055571958199984,1.2959793407636457,0.14075887392900857,0.8404433185245268,1.0,11/27,26.75%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17;LRP1;DNAJA1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.405475263254203,-1.2944667806222905,0.14285714285714285,1.0,1.0,4/21,4.97%,ACBD3;PRRC1;AKAP1;GSKIP
prerank,thiol-dependent deubiquitinase (GO:0004843),0.43383673156157204,1.2924045853924466,0.09539121114683816,0.8469477288745967,1.0,20/83,13.66%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.47845235388829077,1.2893540294371433,0.14116251482799524,0.8509850245252896,1.0,8/35,7.03%,TRMT9B;TRPT1;BCDIN3D;TRMT13;PTRH2;NT5C3A;ALKBH1;AARS1
prerank,protein phosphatase regulator activity (GO:0019888),0.45291249547366924,1.2893406053592058,0.11864406779661017,0.8420918914469737,1.0,21/53,24.61%,EIF2AK2;RCAN1;ARPP19;ANKLE2;PPP2R5C;IGBP1;PPP6R3;PPP2R5D;PPP4R2;CALM3;PHACTR4;PPME1;MGAT5;PPP2R2A;PPP1R7;SET;PPP2R5A;PPP2R3A;CABIN1;ENSA;CALM2
prerank,voltage-gated ion channel activity (GO:0005244),-0.4587578382713162,-1.2891547745102123,0.1519434628975265,0.9933809010649193,1.0,4/14,11.54%,VDAC1;KCND2;GPR89B;GPR89A
prerank,ubiquitin-protein transferase activity (GO:0004842),0.40419435224422695,1.2875823543968894,0.015,0.8415672080881489,1.0,93/346,19.03%,RNF213;PML;TRIM14;IRF2BP1;UBE2L6;DTX3L;RNF214;TRIM25;TRIM45;UBE2W;BIRC2;NFX1;KLHL20;RNF4;TMEM129;HLTF;CUL5;FBXO7;RBCK1;RNF40;TRIM21;RNFT1;BFAR;RNF5;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;VPS11;TRIM39;UBE2M;RNF114;AMFR;RSPRY1;KLHL13;FBXW8;ANAPC4;RNF31;RNF19B;UBE2E3;RBX1;BARD1;PPP1R11;UBE2E1;RING1;TRAF3;ARIH1;BTRC;RNF122;RNF103-CHMP3;TRAF5;TRIM26;RNF149;SMURF1;FBXL14;KLHL9;NEURL1B;NEURL3;UBE2L3;RNF185;KCMF1;MYLIP;SHARPIN;RNF25;BIRC3;NSMCE1;UBE2Q1;DZIP3;NHLRC3;MYCBP2;RNF103;UBR4;LMO7;GID4;RNF166;MIB2;FBXL5;UBE2K;CBLL1;HECTD1;BIRC6;TRIM62;TRIM2;WWP1;MGRN1;RFFL;ASB1;RC3H2
prerank,ion channel activity (GO:0005216),0.4344629726612555,1.28561005564761,0.11351351351351352,0.8416333360952961,1.0,18/80,16.11%,TRPM5;CNGB1;TRPM2;GRIN2D;GRIK3;TMC1;TRPM6;ASIC4;GRIA2;CALHM6;TMEM120B;TRPM3;KCNK3;TRPV4;CHRNB2;TRPM7;GRID1;GRIA4
prerank,histone acetyltransferase binding (GO:0035035),0.5126100848417812,1.2853572303589558,0.1662269129287599,0.8342768923359255,1.0,10/21,25.44%,STAT1;ECD;KANSL1L;MEF2A;TRIP4;CITED2;GLI3;TAF7;SIRT2;EPAS1
prerank,neuropeptide receptor binding (GO:0071855),0.5657089008233405,1.2852597843927887,0.1868279569892473,0.826242480156169,1.0,1/14,0.59%,GAL
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5194944700642105,1.2830467218417152,0.15938303341902313,0.8276668900791914,1.0,9/22,23.82%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17
prerank,glutathione transferase activity (GO:0004364),-0.39592091374981686,-1.279337237728721,0.14218009478672985,0.9876911641759267,1.0,13/23,39.94%,LTC4S;ALOX5AP;GSTO1;GSTA3;PTGES;GSTM1;GSTA4;HPGDS;GSTM5;LANCL1;GSTT1;GSTP1;GSTT2
prerank,ligand-gated cation channel activity (GO:0099094),0.43305685998879057,1.2787476627696688,0.11434735706580366,0.8381881454473487,1.0,9/75,10.13%,CHRNA9;TRPM5;TRPM2;GRIN2D;GRIK3;ASIC4;GRIA2;P2RX4;CCDC51
prerank,single-stranded DNA helicase activity (GO:0017116),0.5318477330110862,1.277673868145535,0.17959183673469387,0.8346338215861826,1.0,6/19,11.65%,MCM2;MCM7;HELQ;RFC4;DHX9;POLQ
prerank,omega peptidase activity (GO:0008242),0.4273127529143192,1.277568358101656,0.09381663113006397,0.8271065808603388,1.0,21/89,13.66%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;GGT7;USP39;ZRANB1;USP45;MINDY3
prerank,damaged DNA binding (GO:0003684),-0.3396123483293765,-1.2769552020119825,0.09285714285714286,0.9516326104668887,1.0,19/44,19.67%,RPA1;RAD18;NBN;CRY2;APTX;ERCC3;XPC;ERCC2;DCLRE1B;SMC6;PNKP;OGG1;NEIL3;FANCG;RAD1;ERCC1;RPA3;XPA;POLD1
prerank,ATPase binding (GO:0051117),0.43066719566125466,1.2754725401466251,0.13636363636363635,0.8283892127399963,1.0,11/71,6.33%,CHMP4A;NR1H2;ABCA1;TOR1AIP2;TOR1AIP1;METTL21A;ATP1B3;USP25;SNX10;ANK1;UBXN1
prerank,G protein-coupled receptor binding (GO:0001664),0.4126952125009232,1.2743410057198572,0.06604747162022703,0.825068731663094,1.0,17/132,9.98%,HSPA1B;WNT11;CALCA;NPB;WNT5A;RTP4;S1PR2;CCL5;REEP2;GNA15;GNA14;WNT7B;TUB;MYOC;BAMBI;HSPA8;ARRB2
prerank,mannose binding (GO:0005537),-0.46877386605117183,-1.273731438623175,0.16225165562913907,0.9234141672411832,1.0,4/12,23.35%,CLN5;CLEC4D;LMAN2L;CLEC6A
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.4859748306245274,-1.2717942749828508,0.18855218855218855,0.8919688734792046,1.0,8/11,46.81%,KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.40126876854236687,1.271075246214636,0.033099297893681046,0.8315766726667195,1.0,73/248,22.48%,RNF213;GBP4;HSPA1B;TOR3A;IRGM;GBP5;CLU;RAB8B;ATL1;GBP3;KIF26A;RAB21;KIF3C;RHOF;GBP2;GPN2;SRPRA;GSPT1;CHD1L;RHEBL1;GBP7;RRAGC;GNA15;RHOJ;GNA14;LSG1;DHX9;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;ABCD1;GCH1;DNM2;RAB14;ARL1;RAB24;SEPTIN9;MYO6;RAC1;EFTUD2;TBCC;HSP90AA1;KIF2A;GPN3;GPN1;GNL2;RAB11A;RAB32;DYNC2H1;ATAD1;HBS1L;RHOT2;MYH9;RAB5B;PIN1;RAP2A;RAB1A;RND2;MTG2;DDX3X;RIT1;MMUT;RHOH;SMCHD1;RHEB;RRAGA;RAB2A;RUVBL2;ENTPD7
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5181921450559396,1.2667939250888942,0.185473411154345,0.8421597156070896,1.0,10/22,23.59%,ZFP36;ILF3;DHX36;ZC3H12A;ZFP36L1;EXOSC9;MEX3D;CPEB2;EXOSC4;ZFP36L2
prerank,neuropeptide receptor activity (GO:0008188),0.48946790010948915,1.2657009967893675,0.17142857142857143,0.8391638736681841,1.0,4/29,11.46%,GAL;TACR1;GPR37;GALR1
prerank,acetyltransferase activity (GO:0016407),0.48435675528565464,1.265008131358783,0.16381418092909536,0.8343273572981508,1.0,5/31,6.26%,SATL1;SAT1;PAFAH1B3;NAA50;SMARCE1
prerank,potassium channel regulator activity (GO:0015459),0.4482636115972149,1.2648168677645817,0.14055299539170507,0.8274678901146085,1.0,17/49,25.79%,KCNMB3;SGK2;SGK3;ARPP19;KCNS3;AKAP9;DLG1;KCNS1;ABCC9;SUMO1;FLNA;ENSA;YWHAE;WNK3;DPP10;DPP6;CHP1
prerank,DNA replication origin binding (GO:0003688),0.5016919368141028,1.2612254184102616,0.19072164948453607,0.8351262974406666,1.0,7/23,12.66%,MCM2;MCM7;MCM4;MCM9;DHX9;ORC3;DDX11
prerank,3'-5' DNA helicase activity (GO:0043138),0.5416794336113431,1.2610257092626138,0.20713305898491083,0.8284095863755815,1.0,5/16,7.30%,ASCC3;MCM2;MCM7;HELQ;DHX9
prerank,deubiquitinase activity (GO:0101005),0.41876407913045244,1.2568852632519443,0.11902231668437832,0.8389837519307585,1.0,20/88,13.66%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3
prerank,hexosyltransferase activity (GO:0016758),0.41390023142045923,1.2565069334534176,0.11006289308176101,0.8331944819794977,1.0,24/101,19.28%,EXT1;HAS3;HYAL1;DPY19L4;HAS1;TMTC1;POMT1;POMT2;PIGV;B4GALT1;B4GALT4;GCNT4;B4GALT5;CSGALNACT2;B3GLCT;MGAT4C;B3GALNT1;B4GALT2;TMTC4;DPY19L1;FUT9;GYG1;GBA2;PIGB
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5104172885094056,1.2540027463279377,0.21456953642384105,0.8362850197928404,1.0,5/20,6.94%,USP50;SENP3;USP25;USP21;SENP5
prerank,poly(U) RNA binding (GO:0008266),0.5146164900141077,1.2487408053917988,0.21146496815286625,0.8505565034723808,1.0,6/20,14.94%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,protein phosphatase binding (GO:0019903),0.4047638384377239,1.247592340486837,0.11475409836065574,0.8479816247814341,1.0,25/117,13.15%,MYOZ2;FCRL6;PPP1R3E;STAT3;ARPP19;ANAPC5;ANKLE2;SMG7;IKBKE;PPP1R3D;CTNNB1;ANK1;IGBP1;PPP6R3;ANAPC4;AKAP11;VRK3;MET;PPP1R11;MAPK14;TRAF3;CDC27;SMG5;RACK1;BAD
prerank,double-stranded DNA binding (GO:0003690),0.38733465232701686,1.2470843666096414,0.011,0.8429624945167857,1.0,72/531,13.03%,DDX60;STAT1;ZBP1;IRF7;PITX2;SYCP1;LMX1A;MSH2;USF2;ETV3;MEF2B;AIM2;TFAP2C;GMEB2;ESRRB;RARG;BBX;TARDBP;TEAD2;ZBTB2;NFKB2;MECP2;CGAS;BATF3;ELK3;CGGBP1;BHLHE40;NKX6-2;KLF15;JUNB;POLG2;ZNF23;SOX9;ZNF76;BCL6;TCF4;ZBTB43;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;DHX9;FEN1;SMAD2;MEIS3;ATF6B;NFIB;HOXA9;POU3F1;HMGB1;ELF4;IRF9;MEN1;NR2C1;PROX1;FOXK1;MAX;XBP1;HMGB3;CUX1;KLF10;TEF;PRKDC;NR3C1;MAU2;HOXB6;DDX11;PRDM4;E2F4
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5187510732646047,1.2464204036972555,0.2164804469273743,0.8384746995905262,1.0,3/18,11.81%,HSD17B7;HSD11B1;DHRS11
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4223449479976694,1.2421342180312656,0.15080213903743314,0.848390783587119,1.0,11/70,11.67%,EXT1;HAS3;HYAL1;HAS1;B4GALT1;GCNT4;CSGALNACT2;XXYLT1;B3GLCT;MGAT4C;B3GALNT1
prerank,galactosyltransferase activity (GO:0008378),0.581540229042919,1.2399933435992938,0.2239884393063584,0.8503909276661477,1.0,4/11,12.38%,B4GALT1;B4GALT4;B4GALT5;B4GALT2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.49897675899534694,1.239119638360184,0.21311475409836064,0.8469671121689785,1.0,4/24,5.93%,CAMK2D;CAMK2B;PNCK;MKNK1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3890572127207007,1.2391187298407158,0.05616850551654965,0.8400895169238178,1.0,50/254,12.73%,HSPA1B;ISG15;PML;UBE2L6;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;UBE2W;TPI1;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;RB1;UBE2L3
prerank,RNA binding (GO:0003723),0.3818147827579356,1.2382139984528693,0.0,0.8370514752344149,1.0,337/1321,19.33%,IFIT3;DDX60;OAS3;IGF2BP1;ZBP1;OASL;EIF2AK2;PARP12;NOL3;OAS2;IFIH1;SAMHD1;HSPA1B;ZNFX1;HELZ2;IFIT1;MCAT;RPS19BP1;MOV10;ZC3HAV1;APOBEC1;IFIT2;ASCC3;BST2;DHFR;DHX58;PWP2;POLR2G;MYBBP1A;PNPT1;KNOP1;CCDC86;CPNE3;TRIM25;TRMT9B;FNDC3A;ZFP36;NFX1;HTATSF1;CSRP1;XRN2;ZC3H7A;ACTN1;ADAR;EIF4A2;DHX33;IGF2BP3;AGO2;TARDBP;SUGP2;RBM14;MECP2;SBDS;HLTF;STAT3;DDX27;MSI1;DDX18;ZNF106;TDRD7;YTHDF1;RPL36;DDX5;ZC3H12C;MAGOHB;HARS2;DDX49;ZFR2;SMG7;PKN2;FLNB;SUMO2;ERAL1;HNRNPH1;TARBP2;DYNC1H1;LARP1;MRPS30;CNOT4;RBMX;SRPRA;COL14A1;SRRT;RSL1D1;ILF3;NOP53;MTHFSD;KPNB1;DHX36;HSP90AB1;NCBP2;GSPT1;TLR8;UBTF;TCOF1;MRPL12;RPL22;XRN1;MRM3;CHERP;HNRNPK;GPATCH1;PRPF40A;NGRN;RCC1L;SLPI;RPS21;MEPCE;PIN4;WDR33;LAS1L;TRMT1;TFB2M;RBMS2;TRNAU1AP;EDF1;FNDC3B;DDX20;CFAP65;DCP2;ALKBH1;MRPL16;HNRNPM;BICC1;AARS1;MRPS35;MRPS28;SEPSECS;RRS1;PPAN;CCT4;SRF;DHX9;NUDT5;CISD2;MAPRE1;HNRNPA2B1;N4BP1;GAR1;PPIA;SF3B6;GFM1;UCHL5;RO60;RAE1;TUFM;NOLC1;YTHDF2;RPL7L1;NONO;SLTM;RNMT;CLK3;HMGB1;BARD1;SRPK1;SLIRP;PPP1R10;HNRNPL;HSPA8;SSRP1;DIMT1;NCOA5;G3BP2;DHX30;STAU1;EIF4H;DUSP14;NPM1;DDX24;ZC3H12A;ZC3H4;CCT3;PUM3;PRR3;FAM98B;RNPS1;SNW1;ZFP36L1;HNRNPDL;DDX50;RBFOX1;HDLBP;TENT5A;RALY;EIF3A;MRPL42;LONP1;SMG5;ABCF1;HNRNPH3;HMGB3;NKAP;PRRC2B;HNRNPA1;CELF6;ILF2;NOP2;PRKDC;PPARGC1A;HOXB6;TRMT10C;DDX54;MRPL4;GTF2E2;KTN1;DDX11;DENR;UBE2L3;TUBB4B;EWSR1;SECISBP2;ZC3H11A;SNRPD2;SNRPD1;RPS6;RACK1;SART1;MATR3;CHTOP;ALG13;MRPS23;EIF4G3;SPATS2;DHX57;ZC3H7B;TIAL1;CLNS1A;EIF2S1;KRI1;DBR1;DUS2;NOP16;EIF1B;ADAT1;WDR43;EXOSC9;EFTUD2;RPN1;DUSP11;RBM45;PCF11;RBM27;NOA1;PATL2;HSP90AA1;RPS11;MAP4;CFAP20;RBM15;DZIP3;DDX39B;MBNL2;RPL30;DAZAP1;ZC3H13;RBFOX3;SNRPG;RBM3;RBM39;PRPF40B;ETF1;NCBP1;DHX16;DDX19B;SNTB2;TAF15;NUDT16;GNL2;RPL32;SF3B4;UBA1;BZW1;SRSF7;PRMT1;RPL23A;MEX3D;RPL11;TUT7;SRSF4;DHX40;DHX37;RTCB;ZBED4;UPF1;METAP2;DDX47;HNRNPA3;YARS2;PUS7;DICER1;METTL14;RPL10A;PRKRA;NUDT4;RPP30;NOL4;PCBP4;PELP1;TLR3;RPS15A;RRP1B;RRP1;CAVIN1;DDX46;MRPL13;LRRFIP1;CWC22;DDX23;ZMAT3;ENDOV;SRBD1;RPP14;MYH9;LSM5;POLR1G;CPEB2;CAPRIN1;TBRG4;RBPMS;RSL24D1;RPL24;EIF4B;UTP3;RPL37A;BUD23;FASTKD2;ZCCHC3;RC3H2;RPL3;MRPS11;ESF1;DDX19A;MRPL40;MRPL22;RPP25L;HNRNPF
prerank,nuclear receptor binding (GO:0016922),0.39827918081747793,1.2348855187757535,0.12748171368861025,0.8440782497752027,1.0,19/111,13.42%,STAT1;OASL;HMGN3;DAXX;PRMT2;DDX5;NCOA1;CTNNB1;ARID1A;TCF7L2;SMARCE1;TACC2;MED12;PROX1;SNW1;PPARGC1A;LCOR;DDX54;BUD31
prerank,anion transmembrane transporter activity (GO:0008509),0.5602545024021862,1.2340961791502592,0.23065476190476192,0.8404235523986484,1.0,5/12,20.24%,ABCC2;SLC19A1;SLC4A2;ABCG2;ABCC5
prerank,ribosomal large subunit binding (GO:0043023),0.5708450073418375,1.2317381790576045,0.23313782991202345,0.8430201715471479,1.0,5/11,18.34%,DHX33;NPM1;EIF6;RBM3;CPEB2
prerank,translation initiation factor activity (GO:0003743),0.4542657990188055,1.231501852658864,0.20048602673147023,0.8373850510248356,1.0,15/36,24.66%,EIF4A2;AGO2;MTIF3;EIF2B2;EIF3A;EIF4G3;EIF2S1;EIF1B;EIF3K;EIF2B5;EIF2B3;EIF5;EIF3I;EIF3C;EIF4E
prerank,solute:proton symporter activity (GO:0015295),0.5307160281517214,1.228287789572758,0.21216407355021216,0.8440169076720868,1.0,5/16,15.59%,MFSD3;SLC15A2;SLC11A2;CTNS;SLC2A9
prerank,NAD+ binding (GO:0070403),0.5619760694424403,1.225955270677294,0.22895125553914328,0.8470059383986478,1.0,2/12,0.64%,PARP9;ZC3HAV1
prerank,lipid phosphatase activity (GO:0042577),0.5440411671626786,1.2235168543072532,0.22620689655172413,0.8502694784086404,1.0,9/14,25.40%,SGPP2;EPHX2;INPP5K;PLPP2;PLPP7;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,manganese ion binding (GO:0030145),0.43669399389972013,1.22221697830499,0.19019836639439908,0.8487332991024837,1.0,16/48,21.74%,XYLT2;SOD2;HMGCL;B4GALT1;FEN1;XXYLT1;PIM1;DYRK2;PAPOLA;FAM20C;GALNT1;NUDT16;MGAT5;GYG1;MTPAP;ABL2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.47703602878938034,-1.221921818932692,0.21846153846153846,1.0,1.0,8/11,24.32%,HSPH1;GRPEL1;SIL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.47703602878938034,-1.221921818932692,0.21846153846153846,1.0,1.0,8/11,24.32%,HSPH1;GRPEL1;SIL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5376122904352131,1.221690222813956,0.20164609053497942,0.844443785484161,1.0,6/15,20.79%,SOCS1;SOCS5;SOCS2;SOCS6;SOCS4;SOCS7
prerank,syntaxin binding (GO:0019905),0.42040474826646845,1.2216679510393331,0.17391304347826086,0.8382183017875786,1.0,20/61,16.42%,ABCA1;CPLX1;STX7;VPS11;VPS54;BAIAP3;CACNA1A;SYT3;STX8;STX16;TMED10;VAMP1;SCFD1;VPS52;VAMP2;NAPA;NAPB;SNAP23;RAB11A;STXBP5L
prerank,N-methyltransferase activity (GO:0008170),0.49883124388407396,1.2170289363301316,0.22178477690288714,0.850148651048579,1.0,8/20,16.50%,ZCCHC4;TRMT1;TFB2M;SETD3;RNMT;DIMT1;PRMT1;METTL15
prerank,DNA-binding transcription factor binding (GO:0140297),0.3893094033275182,1.215402732892073,0.1082995951417004,0.8505012608090878,1.0,48/189,19.46%,STAT1;PITX2;DAPK3;USF2;ZBTB17;DDRGK1;STAT3;RBL1;MTA3;CGGBP1;MAD2L2;BHLHE40;CTNNB1;TCF7L2;DDX20;USF1;SRF;DHX9;MTA2;SMAD2;DACT1;LMO2;HMGB1;SCX;CRTC1;DUSP26;NPM1;SIK1;NEK6;LDB2;LDB1;RB1;MIER1;CRTC3;BBS2;PIAS1;MEF2A;PPARD;PIAS2;RBPJ;CHCHD2;ZBTB49;CXXC5;HDAC1;CTBP1;PRRX1;PSMD9;BEX1
prerank,ATPase activator activity (GO:0001671),0.4937398287566976,1.2148172329587121,0.24338624338624337,0.8466675381062427,1.0,5/20,9.90%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6
prerank,growth factor activity (GO:0008083),0.40481973821448797,1.212328935759044,0.19483315392895587,0.8501163663763107,1.0,8/74,11.35%,AGT;BDNF;TGFA;OSGIN1;CSF1;GDNF;VEGFD;FGF9
prerank,mannosyltransferase activity (GO:0000030),0.4921262802119204,1.2093669907950872,0.24048913043478262,0.8554583396479019,1.0,8/21,19.28%,DPY19L4;TMTC1;POMT1;POMT2;PIGV;TMTC4;DPY19L1;PIGB
prerank,protein homodimerization activity (GO:0042803),0.3748865913694605,1.2016421550002245,0.027,0.8798010283306601,1.0,153/589,22.44%,STAT1;GBP4;TPST1;CLTRN;PML;CHMP4A;CHMP4B;TRIM14;AGXT;EXT1;MSH2;GBP5;BST2;DAPK3;USF2;PPCS;CAMK2D;XDH;NOD1;SPPL2A;DPY30;ABCG1;TPI1;GRHPR;PRMT2;B2M;CAMK2B;ACTN1;GBP3;CHEK2;ACVR1;CANT1;STAT3;RNF40;TRIM21;PAFAH1B3;GBP2;TARBP2;BHLHE40;PEX7;ZHX3;GOLGA5;CCL5;MZF1;HSP90AB1;DCK;TNNC1;KMT2A;FGFR2;SH3GLB1;ZBTB38;WDR54;USF1;TFAP2B;ABCB9;DUSP29;CSF1;IDH1;CPQ;SRF;ST6GAL1;NUDT5;CISD2;TPD52L1;BANF1;CCDC88A;HSD11B1;GDNF;CST7;NFS1;BARD1;RAP1GAP;TMEM266;VAPB;MKLN1;ABCD1;HOOK1;GCH1;SNX9;NPM1;ATIC;NECTIN3;IL17D;CEP131;SRGAP2;STARD3;LDB1;EPHX2;APOE;ENPP1;RACK1;MASP1;SHMT1;SPPL3;CRPPA;HSP90AA1;GEN1;BMPR1A;STK25;CCDC66;NRBP1;NUDT16;TDG;PGRMC1;DSCAML1;MIGA2;IRAK1;SNX1;ZBTB4;YARS2;PRKRA;BAX;LRRFIP1;CLCN1;GLB1;ABCB7;TARS2;MYH9;HM13;ACOX1;GYG1;PSMD7;RBPMS;TERF2;TAP1;ERN1;RIPK2;ABCG2;TYROBP;POU3F3;RPE;PSMF1;APPL2;TKT;TPD52;LHPP;ZDHHC3;MMUT;GADD45A;MCL1;MTPAP;TENM4;TSG101;SMCHD1;PON3;S100A13;CHMP1A;SNX2;RRAGA;STUB1;HMGCS1;IDE;SSBP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5357903400129234,1.2006335463168987,0.26750700280112044,0.8777036749035974,1.0,4/14,29.07%,RDH11;RDH10;AKR1A1;DHRS3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.45728319516729166,-1.1994948451157643,0.2305084745762712,1.0,1.0,4/12,23.78%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,tau-protein kinase activity (GO:0050321),-0.37815923000784296,-1.1987099612304428,0.20425531914893616,1.0,1.0,6/20,14.20%,DYRK1A;ROCK1;MARK4;GSK3B;TTBK1;TTBK2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.42790057128672526,1.1972467358589187,0.2390300230946882,0.8856559303048623,1.0,25/49,26.04%,PARP10;UBQLN2;IKBKE;UBXN1;UBQLN1;TNIP1;ZRANB3;SHARPIN;ZRANB1;DZIP3;TNIP2;SPRTN;TNIP3;BABAM2;TAB3;ATRIP;ZFAND6;OPTN;UBQLN4;PSMD4;VCP;HDAC6;UBL7;RAD23A;ABRAXAS2
prerank,chloride transmembrane transporter activity (GO:0015108),0.5034375669248149,1.1971055995255673,0.26666666666666666,0.880120619780405,1.0,5/16,15.49%,SLC26A1;SLC12A5;CLCN6;SLC26A2;CLCN7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.41957308796149156,1.1959783664509287,0.21129943502824858,0.8785761903384445,1.0,14/55,16.77%,SLC38A2;SLC38A1;SLC46A1;SLC19A1;SLC38A3;SLC38A6;SLC25A10;PDPN;SLC7A6;ABCC1;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,E-box binding (GO:0070888),0.44846365140812844,1.1952386547097433,0.22976190476190475,0.8755010816948103,1.0,7/34,11.57%,CIART;BHLHE40;TCF4;SNAI2;SCX;MAX;MITF
prerank,chloride channel inhibitor activity (GO:0019869),0.5631107769941204,1.1944878751333667,0.2600896860986547,0.872552171554312,1.0,5/10,24.86%,STX7;STX8;VTI1B;WNK3;CFTR
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.2876862935754487,-1.1927964963826345,0.0898876404494382,1.0,1.0,12/60,11.22%,TAB1;PPP3R1;PPM1E;PPM1G;CTDSPL2;PPP4C;CTDNEP1;LRRC40;PPM1L;LRRK1;CTDP1;CTDSPL
prerank,nuclease activity (GO:0004518),0.4182206770766962,1.1916922249250306,0.2237442922374429,0.877770890889189,1.0,12/52,14.16%,SAMHD1;XRN2;AEN;RNASEH2A;FEN1;N4BP1;RNASE7;ZC3H12A;ENPP1;RNASE1;DIS3L2;REXO1
prerank,lysine-acetylated histone binding (GO:0070577),0.49344701098232363,1.1905644912824371,0.25067385444743934,0.8703343273201795,1.0,7/20,16.75%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),0.49344701098232363,1.1905644912824371,0.25067385444743934,0.8703343273201795,1.0,7/20,16.75%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,alkali metal ion binding (GO:0031420),-0.43680682716093333,-1.1901761887379452,0.23548387096774193,1.0,1.0,2/13,1.78%,CAPN3;DRG1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5272669273772499,1.1900419215118199,0.26420454545454547,0.8665506152460891,1.0,5/15,19.75%,SAP30L;RUBCNL;SH3PXD2B;PHLDA3;PLA2G4E
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5517619738405504,1.1886586060169113,0.2631578947368421,0.8665360282378953,1.0,4/12,12.48%,IRS1;SOCS1;INSR;SOCS2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5494409644418496,1.188168959185696,0.2809667673716012,0.8628069019018829,1.0,3/12,7.50%,XDH;FXN;CISD2
prerank,PDZ domain binding (GO:0030165),-0.27801204009650227,-1.1873307631494017,0.15384615384615385,0.9811257039131102,1.0,24/61,28.70%,DOCK4;SDC2;SRR;TGFBR3;DLG4;TBC1D10A;CCDC88C;CIT;SYNJ2;NSF;GNG5;FZD7;F11R;CRIM1;CXADR;SLC26A6;SNTG2;FZD4;KIF14;GRID2;ATP2B2;ATP2B4;FZD2;PRKN
prerank,RNA polymerase II complex binding (GO:0000993),0.4425387242170019,1.1856065535883842,0.23304562268803947,0.86696204715625,1.0,11/32,16.96%,ESRRB;AGO2;UVSSA;SCAF1;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.41903772733468264,1.182658446400672,0.22613636363636364,0.8722455390211423,1.0,14/49,21.50%,SAMHD1;DUSP3;PDXP;SBF1;DUSP28;EPHX2;DUSP10;DUSP16;DUSP11;ENPP6;DUSP8;SACM1L;LHPP;PGAM5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5347670444921695,1.1804849220396056,0.2929745889387145,0.8748739172518366,1.0,4/12,13.15%,NOD1;CTSH;RACK1;BAD
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4841200100426814,-1.1802775070408922,0.2694610778443114,0.976427952289476,1.0,8/10,51.61%,SLC6A11;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2;SLC6A1
prerank,CCR chemokine receptor binding (GO:0048020),0.46081249017930886,1.1794730344958306,0.24968474148802017,0.8732130844653209,1.0,5/28,13.88%,CCL7;CCL5;CX3CL1;CCL14;NARS1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.48563591271020495,1.177805948971621,0.27380952380952384,0.8738146608409826,1.0,6/21,11.65%,POLE2;POLD4;POLM;POLB;POLK;POLQ
prerank,chloride channel regulator activity (GO:0017081),0.5133930451757187,1.1776428107011907,0.29298486932599727,0.8688603771284753,1.0,4/14,13.59%,SGK3;STX7;STX8;VTI1B
prerank,cytokine receptor binding (GO:0005126),0.3944638115697302,1.1764273867341604,0.21103896103896103,0.8679506331595025,1.0,18/83,18.74%,CRLF1;TNFSF9;KITLG;USP15;CCL5;IL27;ERAP1;CSF1;SMAD2;TIMM50;VEGFD;SOCS2;IL1RAP;JAK2;PIBF1;IL18;SPRED1;CD300LF
prerank,guanyl ribonucleotide binding (GO:0032561),0.37506010221270164,1.172990611048922,0.1358148893360161,0.8754528027193551,1.0,43/196,16.77%,GBP4;CNGB1;GBP5;TUBD1;ARF3;TUBB2B;RAB8B;ATL1;GBP3;RAB21;RHOF;GBP2;RHEBL1;RAB12;GBP7;RRAGC;SLC19A1;RHOJ;LSG1;ARF5;RAB22A;AGAP2;SEPHS1;RAPGEF2;RAB11B;RAB5C;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;TUBB4B;ARL5C;RAC1;NOA1;NUDT16;GNL2;ARF4;GLUD1;RAB32;RANBP17
prerank,phosphatidylinositol binding (GO:0035091),0.3905774737174346,1.1724218194368725,0.2126068376068376,0.8721626560614928,1.0,34/91,24.21%,GPAA1;THY1;PLEKHN1;GAP43;ITPR1;GRAMD2A;PITPNM1;SNX10;DENND1A;RUBCNL;CCDC88A;WDFY1;PLEKHF2;SNX9;ANKFY1;RUBCN;SNAP91;RPH3A;SNX1;SNX24;TULP3;NUMA1;DENND1B;PIGK;APPL2;TNFAIP8L3;SNX2;ESYT2;ZFYVE1;EEA1;PITPNA;SNX17;SNX12;WDFY3
prerank,DNA polymerase activity (GO:0034061),0.4781089921631608,1.1712689578703623,0.28083989501312334,0.871186232974198,1.0,6/22,11.65%,POLE2;POLD4;POLM;POLB;POLK;POLQ
prerank,protein phosphatase 2A binding (GO:0051721),0.4697942326942135,1.1708700393128604,0.2840909090909091,0.8672660574481355,1.0,13/23,28.18%,ARPP19;ANKLE2;SMG7;IGBP1;SMG5;MASTL;PPME1;MFHAS1;STRN3;ENSA;GRIN3A;BOD1;CTTNBP2NL
prerank,DNA binding (GO:0003677),0.3615262978035253,1.1654133443176575,0.029,0.8823110465266828,1.0,130/694,17.01%,DDX60;STAT1;ZBP1;OASL;IRF7;SAMHD1;SYCP1;SIM1;TAF4B;NR1H2;MSH2;ESR2;USF2;AIM2;POLR2G;MYBBP1A;TFAP2C;MCM2;ESRRB;RARG;TIMELESS;SAP30L;TARDBP;ZFPL1;RNF4;MECP2;STAT3;TIGD2;CGAS;ARID5B;SPATA24;CGGBP1;MCM7;NKX6-2;SRRT;ILF3;DHX36;RNF11;TIPIN;JUNB;TLR8;MCM4;POLG2;XRN1;RFC1;SOX9;ARID1A;SLPI;ZNF76;CDT1;BCL6;TCF7L2;TCF4;MCM9;BRIP1;USF1;TFAP2B;NFATC2;RAD51C;SNAI2;DHX9;FEN1;SMAD2;MEIS3;BANF1;ERCC4;GTF3C5;DNMT3A;MPG;SLTM;NFIB;POU3F1;JRKL;HMGB1;SCX;DNMT1;APP;ZMYM3;RORA;MEN1;LIN9;POGK;BPTF;NR2C1;TWNK;PROX1;ZC3H12A;MAX;CTCF;RYBP;XBP1;LONP1;POLQ;HMGB3;CUX1;ZNF423;TRIM26;HNRNPA1;ILF2;PRKDC;MAU2;PPARGC1A;DDX11;DNASE2;ZNF35;E2F4;STN1;ZBTB21;IKZF1;SMARCA1;DCLRE1A;SOX2;RTF2;POU6F1;CAMTA2;ERF;TDG;MEF2A;NHEJ1;ZMYM6;CARF;PPARD;SPRTN;GTF3C3;DENND4A;SREBF1;ZBTB4;RBPJ;HMBOX1;CHCHD2
prerank,zinc ion binding (GO:0008270),0.36307200588589345,1.164320958017034,0.13513513513513514,0.8811854818003279,1.0,62/293,16.02%,IFIH1;SAMHD1;TNFSF10;ADAM33;DHX58;GALT;SORD;BIRC2;CSRP1;SAP30L;ZFPL1;ADAMTS3;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;KPNB1;RNF11;ZDHHC20;ZCCHC4;KMT2A;ZNF2;SLC30A5;ERAP1;MT3;SEC24D;CYLD;ATAD3A;DPP3;SIRT6;SEC23A;P2RX4;PAPPA;TK1;MNAT1;WDFY1;ARIH1;GCH1;TIMP2;CHORDC1;CTCF;MYRIP;NPEPPS;FBXL19;ENPP1;LIMS1;CXXC4;PITRM1;CA2;SHMT1;TET2;ENPP5;MYCBP2;PAM;TMEM163;SEC24A;ACER3;RPH3A;KDM7A
prerank,methylation-dependent protein binding (GO:0140034),0.4096871517925897,1.16290478734114,0.2381489841986456,0.8810717269881597,1.0,18/57,23.64%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;CHD8
prerank,tRNA methyltransferase activity (GO:0008175),0.49996106227461923,1.1624801581118878,0.28843537414965986,0.8773883826570629,1.0,7/16,22.69%,TRMT9B;BCDIN3D;TRMT13;THUMPD3;TYW3;TARBP1;TRDMT1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3728631383781904,1.1608477091029794,0.22131147540983606,0.8785041410447846,1.0,35/134,22.19%,SLC25A22;ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC2A6;SLC25A1;SLC46A1;SLC19A1;SLC52A2;SLCO1B1;SLC38A3;SLC35B1;SLC38A6;PDPN;SLC25A25;ABCC1;SLC26A2;SFXN2;SLC35B4;CTNS;SLC35A3;SLC25A12;SLC36A4;SLC35D1;SFXN1;ABCG2;SLC25A15;ABCC5;SLC5A6;MFSD12;SLC6A6;SLC1A3
prerank,bHLH transcription factor binding (GO:0043425),0.48276744334221156,1.160836276549291,0.28688524590163933,0.8733422075598171,1.0,5/19,9.08%,USF2;BHLHE40;USF1;LMO2;SCX
prerank,LRR domain binding (GO:0030275),0.5106319186752077,1.1599649715605074,0.29362880886426596,0.871183335880258,1.0,3/14,7.87%,DAPK3;ZXDC;MRTFA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3676913990673145,1.15884435830543,0.16332665330661322,0.870144393422686,1.0,71/232,23.39%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;BFAR;RNF5;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;VPS11;TRIM39;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;CBX4;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;NSMCE2;NSMCE1;NHLRC3;MYCBP2;UBR4;PIAS1;PIAS2;GID4;RNF166;CBLL1;HECTD1;TRIM62;TRIM2;WWP1;MGRN1;RFFL;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;STUB1;SMURF2;UBR2;PELI1;CUL3;XIAP
prerank,mRNA binding (GO:0003729),0.36627830590385313,1.1581682992443612,0.14744232698094284,0.8677675455156322,1.0,60/249,19.11%,IGF2BP1;DHFR;ZFP36;DHX33;IGF2BP3;AGO2;TARDBP;RBM14;TDRD7;RNF40;YTHDF1;DDX5;ZC3H12C;LARP1;RBMX;RSL1D1;DHX36;NCBP2;HNRNPK;AUH;SLPI;RBMS2;HNRNPM;DHX9;HNRNPA2B1;N4BP1;SF3B6;YTHDF2;HNRNPL;G3BP2;ZC3H12A;PUM3;MARF1;RNPS1;ZFP36L1;RBFOX1;HDLBP;EIF3A;CELF6;DENR;SECISBP2;ZC3H11A;EIF4G3;SHMT1;PCF11;RBM15;DAZAP1;RBFOX3;ETF1;NCBP1;NUDT16;SRSF4;METTL14;PCBP4;MRPL13;SRBD1;CPEB2;RBPMS;RC3H2;MRPS11
prerank,aminopeptidase activity (GO:0004177),0.44813588577909785,1.156994686858277,0.27122940430925224,0.8671387711747617,1.0,10/26,24.07%,LAP3;MMP14;ERAP1;CTSH;NPEPPS;KDM8;METAP2;MMP15;TRHDE;RNPEP
prerank,clathrin adaptor activity (GO:0035615),0.4990616332685727,1.1566601203856595,0.27197802197802196,0.8634602905194756,1.0,6/15,17.48%,AP2A1;LDLRAP1;AP2S1;STON1;DAB2;STON2
prerank,transition metal ion binding (GO:0046914),0.3596596399748424,1.1535700396602953,0.11311311311311312,0.8696904219859026,1.0,81/397,16.02%,IFIH1;SAMHD1;TNFSF10;LOXL2;ADAM33;XYLT2;DHX58;GALT;SORD;BIRC2;ETHE1;CSRP1;SAP30L;ZFPL1;ADAMTS3;SOD2;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;KPNB1;RNF11;ZDHHC20;ZCCHC4;KMT2A;ZNF2;NFU1;SLC30A5;ERAP1;MT3;HMGCL;SEC24D;SLC11A2;CYLD;ATAD3A;B4GALT1;FEN1;ABCE1;DPP3;SIRT6;SEC23A;P2RX4;PAPPA;SCD5;PRNP;TK1;MNAT1;WDFY1;ARIH1;GCH1;TIMP2;CHORDC1;CTCF;XXYLT1;PIM1;DYRK2;MYRIP;NPEPPS;FBXL19;ENPP1;LIMS1;CXXC4;PAPOLA;PITRM1;CA2;SHMT1;FAM20C;TET2;ENPP5;MYCBP2;PAM;TMEM163;GALNT1;SEC24A;NUDT16;ACER3;RPH3A;KDM7A
prerank,ATP binding (GO:0005524),0.3628404816248131,1.153245345459087,0.15609264853977844,0.8659288178489654,1.0,64/266,21.22%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;ABCE1;EIF2B2;P2RX4;INSR;UBA2;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;DYRK2;NEK6;ENPP1;PAPOLA;MINK1;HSP90AA1;BMPR1A;TDG;OXSR1;TBCK;YARS2;SNRK;MYH9;HSPA14;MARK1;BRSK1;STK3;TAP1;ERN1;ACVRL1;ABCD4;TLK2;STK11;MAP4K2;MTPAP
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4697134151354231,1.1527964990040005,0.28741721854304636,0.8625795787808611,1.0,3/21,15.18%,CHRNA9;P2RX4;CHRNB2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4166768819026282,1.1503443238691513,0.2875739644970414,0.8662730921760162,1.0,8/42,7.55%,CCNL1;CCNJ;CCND2;CCNL2;CDKN2D;CCND1;CCNT2;CNPPD1
prerank,WW domain binding (GO:0050699),0.4504800931697368,1.148929529369472,0.29396984924623115,0.8663823420203249,1.0,6/26,12.83%,DAZAP2;PMEPA1;TRAF4;RAPGEF2;TCEAL3;TCEAL6
prerank,ribonuclease activity (GO:0004540),0.395698200920499,1.146756313210719,0.2807215332581736,0.8697693311841417,1.0,12/56,14.09%,SAMHD1;AGO2;NOB1;ZC3H12C;CNOT7;RNASEH2A;N4BP1;RNASE7;ZC3H12A;RNASE1;DIS3L2;EXOSC9
prerank,gamma-tubulin binding (GO:0043015),-0.36168883090882575,-1.1460348207425335,0.2641509433962264,1.0,1.0,10/21,12.84%,PAK1;BLOC1S2;MARK4;TUBGCP3;NDRG1;TUBGCP4;TUBGCP6;TUBGCP2;OFD1;RACGAP1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.41798624246205807,-1.1453483839516725,0.286231884057971,1.0,1.0,4/13,23.78%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,titin binding (GO:0031432),0.509120482664768,1.1441218192517506,0.3338048090523338,0.8742548193619305,1.0,2/13,3.83%,CAMK2D;ACTN2
prerank,ubiquitin-specific protease binding (GO:1990381),0.46768720502451744,1.1414994170104478,0.3131443298969072,0.8787865617863456,1.0,9/19,26.55%,AMFR;CHMP3;LCOR;SART3;SUMO1;VCP;DERL2;RAD23A;PTEN
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4241991163161846,1.1408864078520147,0.2939729397293973,0.8760693706634748,1.0,17/33,28.13%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,low-density lipoprotein particle binding (GO:0030169),0.4903374430099162,1.1390012110469847,0.31409395973154364,0.878157086700677,1.0,6/16,20.93%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4079038758464163,1.1386225175849598,0.2974828375286041,0.8747815265537786,1.0,10/48,17.44%,TRPM5;TRPM2;TRPM6;SLC46A1;CALHM6;TRPM3;DMAC2L;TRPV4;TRPM7;ATP6V1B2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3608206819378374,1.1372362592157268,0.20381526104417672,0.8748739172518366,1.0,69/228,23.39%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;BFAR;RNF5;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;VPS11;TRIM39;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;UBE4B;NSMCE1;NHLRC3;MYCBP2;UBR4;GID4;RNF166;UBE2K;CBLL1;HECTD1;TRIM62;TRIM2;WWP1;MGRN1;RFFL;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;STUB1;SMURF2;UBR2;PELI1;CUL3;XIAP
prerank,sterol transfer activity (GO:0120015),0.47906013963220184,1.1370268440035118,0.30273972602739724,0.8709886025449318,1.0,7/17,19.13%,ABCA1;ABCG1;NPC2;GRAMD1C;OSBP;MTTP;OSBPL2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5065655595183866,1.1353738940199498,0.33578792341678937,0.8725148302978183,1.0,4/14,13.15%,NOD1;CTSH;RACK1;BAD
prerank,calcium channel inhibitor activity (GO:0019855),0.5313598519545135,1.134214954614072,0.33183856502242154,0.8719737013105353,1.0,2/11,5.29%,ITPR1;SLC30A1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3564654760776188,1.1340907846058197,0.1708542713567839,0.8677773738406771,1.0,72/291,21.22%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;SLC19A1;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;RAPGEF2;ABCE1;EIF2B2;P2RX4;INSR;UBA2;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;DYRK2;NEK6;ENPP1;PAPOLA;MYO6;MINK1;HSP90AA1;BMPR1A;TDG;GLUD1;OXSR1;GCLC;TBCK;YARS2;SNRK;ACSS2;MYH9;HSPA14;MARK1;BRSK1;STK3;PDE4B;TAP1;ERN1;CNBD2;ACVRL1;ABCD4;TLK2;STK11;MAP4K2;MTPAP
prerank,death domain binding (GO:0070513),0.5211223009131271,1.1339846722669082,0.30523255813953487,0.8635392992646005,1.0,5/11,21.19%,IRGM;RACK1;BAX;CRADD;MCL1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5366101123717602,1.1337439235274396,0.31790123456790126,0.8598887853374915,1.0,2/10,6.37%,SLCO1C1;SLCO1B1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3543168802364869,1.1316042491907083,0.139,0.8629222811703594,1.0,112/431,22.39%,OAS3;GBP4;OAS2;HSPA1B;MSH2;ABCA1;GBP5;DAPK3;TUBD1;ABCG1;ARF3;TUBB2B;ATL1;GBP3;MLKL;ACVR1;HASPIN;RAB21;RHOF;STK38L;GBP2;DHX36;HSP90AB1;PEAK1;RHEBL1;GBP7;NOL9;RRAGC;RHOJ;PFKM;MKNK1;LSG1;ARF5;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;RAB22A;AGAP2;SEPHS1;RAB11B;ABCE1;EIF2B2;P2RX4;INSR;UBA2;SRPK1;ABCD1;TUBE1;HSPA8;PRKAG1;GCH1;DNM2;NUAK2;HSPA4;RAB14;ARL1;BCKDK;SIK1;LONP1;PIM1;ABCF1;DYRK2;NEK6;TUBB4B;ENPP1;ARL5C;PAPOLA;RAC1;NOA1;MINK1;HSP90AA1;BMPR1A;NUDT16;TDG;GNL2;ARF4;GLUD1;OXSR1;RAB32;TBCK;YARS2;RANBP17;SNRK;RHOT2;MYH9;HSPA14;MARK1;BRSK1;MFHAS1;STK3;TAP1;RAP2A;ERN1;TGM2;ACVRL1;RND2;MTG2;ABCD4;TLK2;STK11;RIT1;MAP4K2;MTPAP;RHOH;RHEB;PNPLA8;AKT3;RRAGA;IDE;RAB2A
prerank,poly-pyrimidine tract binding (GO:0008187),0.4567475775042731,1.1306078242787947,0.3231162196679438,0.8618645517835951,1.0,6/23,14.94%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.44378257494215234,-1.1304471089473118,0.267515923566879,1.0,1.0,4/11,32.06%,DDAH1;PADI4;DDAH2;ARG2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.37681043887166865,1.127887684036323,0.2818574514038877,0.8673432292914603,1.0,18/85,20.32%,AOAH;PNPLA2;ABHD2;PAFAH1B3;PLA2G12A;PTRH2;ABHD8;AARS1;LIPC;PGLS;LYPLA2;PNPLA6;CA2;ABHD3;TARS2;PLA2G4E;PNPLA3;PLA2G6
prerank,cyclic nucleotide binding (GO:0030551),0.45284131928892213,1.125929633592345,0.3380829015544041,0.8696242468117179,1.0,3/21,8.09%,CNGB1;SLC19A1;RAPGEF2
prerank,methylated histone binding (GO:0035064),0.39070401885144096,1.1223086376201663,0.29867256637168144,0.8778273711656394,1.0,20/62,23.86%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;DPF2;CHD8;TAF7
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.35237795168712926,-1.1207576554981806,0.29411764705882354,1.0,1.0,7/22,13.09%,ATP6V0A1;ATP6V1E1;ATP2A2;ATP6V1C1;ATP2C1;ATP6V1D;ATP6V1A
prerank,transforming growth factor beta binding (GO:0050431),-0.34568144793851774,-1.1183500426822928,0.2952755905511811,1.0,1.0,4/23,6.18%,TGFBR3;LTBP1;ITGAV;TWSG1
prerank,glutamate receptor activity (GO:0008066),0.4618262797076909,1.1143860672064552,0.3386880856760375,0.9017612102255905,1.0,10/19,25.21%,GRIN2D;GRIK3;GRIA2;GRID1;GRIA4;GRIK4;GRM7;GRM4;GRIK2;GRIK5
prerank,MAP kinase phosphatase activity (GO:0033549),0.5044328984681459,1.1120086387123782,0.359612724757953,0.9059577826874285,1.0,5/12,18.47%,DUSP3;DUSP29;DUSP10;DUSP16;DUSP8
prerank,DNA secondary structure binding (GO:0000217),0.4107667554575049,1.1102809539656036,0.35441527446300713,0.9077290393815349,1.0,8/31,15.02%,MSH2;KMT2A;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,RNA polymerase binding (GO:0070063),0.4600231662347536,1.1081999769196187,0.33902759526938236,0.9102307604920639,1.0,5/18,7.30%,ZFP36;PKN2;TCERG1L;CCNT2;DHX9
prerank,nuclear receptor coactivator activity (GO:0030374),0.3901032972704129,1.107341721942003,0.3474770642201835,0.9089047632862858,1.0,9/52,13.42%,HELZ2;ACTN1;RBM14;RNF4;NCOA1;SRA1;MED12;PPARGC1A;BUD31
prerank,GTP binding (GO:0005525),0.35520421796085255,1.1006458568929551,0.30474268415741673,0.9281606262106723,1.0,37/172,16.77%,GBP4;GBP5;TUBD1;ARF3;TUBB2B;ATL1;GBP3;RAB21;RHOF;GBP2;RHEBL1;GBP7;RRAGC;RHOJ;LSG1;ARF5;RAB22A;AGAP2;SEPHS1;RAB11B;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;TUBB4B;ARL5C;RAC1;NOA1;NUDT16;GNL2;ARF4;GLUD1;RAB32;RANBP17
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4208332062428777,1.0986903886579305,0.3726937269372694,0.9308112119273253,1.0,11/30,24.61%,NOL3;BIRC2;MT3;CST7;BIRC3;CD27;BIRC6;PTTG1;PRDX3;XIAP;TNFAIP8
prerank,telomerase RNA binding (GO:0070034),0.4480344387871577,1.098353888793036,0.35742444152431013,0.9274033407580508,1.0,6/22,11.62%,SMG7;DHX36;XRN1;DCP2;GAR1;SMG5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4042055264622474,1.0953875874260557,0.3511543134872418,0.9333736633901587,1.0,17/33,28.13%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,single-stranded DNA binding (GO:0003697),0.3612036860938738,1.0946284681098617,0.3252375923970433,0.9316961094082897,1.0,16/93,13.67%,SAMHD1;MSH2;POLR2G;MCM2;MCM7;DHX36;MCM4;MCM9;DHX9;ERCC4;HMGB1;TWNK;LONP1;HNRNPA1;DDX11;STN1
prerank,endopeptidase activator activity (GO:0061133),0.5127815735932918,1.0928957230751715,0.3786259541984733,0.9333295944047164,1.0,7/10,27.52%,PSME2;PSME3;APH1A;APH1B;ADRM1;PSENEN;VSIR
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.33777858348874684,1.0911754087975465,0.138,0.9348299861076793,1.0,131/831,16.06%,STAT1;STAT2;NLRC5;IRF7;PITX2;SIM1;LHX2;LMX1A;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;TCF24;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;NFX1;BBX;TEAD2;ZBTB2;NFKB2;STAT3;ZFP37;BATF3;RBL1;ZNF471;ELK3;RUNX1;NACC1;BHLHE40;NKX6-2;RBMX;KLF15;CIC;DHX36;MZF1;NFXL1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;BCL6;TCF7L2;TCF4;NFKB1;ZBTB43;CREBRF;ZBTB38;BACH1;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;DHX9;ETV6;TBPL1;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;TFDP1;DNMT3A;AEBP1;NFIB;ATF1;HOXA9;POU3F1;SCX;DACH2;RORA;ELF4;IRF9;ZSCAN20;BPTF;NR2C1;PROX1;FOXK1;MAX;CTCF;ZBTB5;TFDP2;XBP1;MITF;SKIL;CUX1;KLF10;ZNF423;RELB;TEF;NR3C1;REL;HOXB6;RB1;PRDM4;ZNF35;E2F4;PGBD1;ST18;IKZF1;CASZ1;BCL11B;ZNF418;MYPOP;SOX2;RREB1;MYB;CREB5;ZBTB34;POU6F1;ZBTB24;SOX5;KLF16;GTF2IRD1;MEF2A;CARF;PPARD;PROX2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3615231303360232,1.0903656766459198,0.3372216330858961,0.9332279135705657,1.0,10/82,11.79%,AGT;BST2;SERPINC1;SLPI;UCHL5;CST7;APP;PRNP;TIMP2;USP14
prerank,calcium-release channel activity (GO:0015278),0.4628490415881209,1.0902595211426462,0.3744740532959327,0.9292219478343176,1.0,3/17,12.50%,TRPM2;ITPR1;MCOLN2
prerank,ligand-gated ion channel activity (GO:0015276),0.41500361580515976,1.0891647479355187,0.35785536159601,0.928611964425257,1.0,7/30,16.11%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,monocarboxylic acid binding (GO:0033293),-0.35865366941487753,-1.0889178897184544,0.2916666666666667,1.0,1.0,4/18,12.18%,NAPEPLD;RXRA;RARA;NR2F2
prerank,Hsp90 protein binding (GO:0051879),0.4071414953894498,1.0867937778125023,0.3674698795180723,0.9326179486239957,1.0,14/33,25.12%,NOD2;KDR;CHORDC1;NR3C1;HDAC8;TELO2;UNC45A;PTGES3;AHSA1;TSC1;ERN1;STUB1;HDAC6;STIP1
prerank,amyloid-beta binding (GO:0001540),0.36979123818737614,1.0854606156817679,0.344644750795334,0.932753019861075,1.0,21/79,18.15%,ITGA2;CLU;CLSTN1;PFDN5;EPHA4;GRIA2;CACNA1A;INSR;LDLRAP1;PRNP;LRPAP1;SORL1;APOE;PFDN4;FCGR2B;APBB1;TLR2;PGRMC1;GRIA4;ITM2C;LDLR
prerank,ligand-gated channel activity (GO:0022834),0.41501373003330133,1.0847188702179902,0.370138017565872,0.931021831693293,1.0,7/29,16.11%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,cholesterol transfer activity (GO:0120020),0.45967178394334474,1.0801381255591722,0.38419618528610355,0.9418324258353504,1.0,6/16,19.13%,ABCA1;ABCG1;NPC2;GRAMD1C;MTTP;OSBPL2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4380925955857055,1.075771287400775,0.3790523690773067,0.9527743599101832,1.0,6/22,13.24%,DUSP3;SBF1;DUSP29;PPM1F;DUSP10;DUSP16
prerank,GTPase activity (GO:0003924),0.34417818689165514,1.075714368346742,0.3185483870967742,0.9486665978592002,1.0,57/192,23.17%,GBP4;IRGM;GBP5;RAB8B;ATL1;GBP3;RAB21;RHOF;GBP2;GPN2;SRPRA;GSPT1;RHEBL1;GBP7;RRAGC;GNA15;RHOJ;GNA14;LSG1;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;GCH1;DNM2;RAB14;ARL1;RAB24;SEPTIN9;RAC1;EFTUD2;TBCC;GPN3;GPN1;GNL2;RAB11A;RAB32;HBS1L;RHOT2;RAB5B;RAP2A;RAB1A;RND2;MTG2;DDX3X;RIT1;MMUT;RHOH;RHEB;RRAGA;RAB2A;ENTPD7;OPA1;RAB29
prerank,magnesium ion binding (GO:0000287),0.3473261167064251,1.0721719415655226,0.3551020408163265,0.956586197267501,1.0,43/135,22.30%,XYLT2;MSH2;STK38L;DHX36;RRAGC;PDXP;NT5C3A;HMGCL;IDH1;NUDT5;FEN1;PGM1;UBA2;SRPK1;NUAK2;HPRT1;XXYLT1;SIK1;DYRK2;NEK6;EPHX2;PAPOLA;DIS3L2;GEN1;NUDT16;TDG;OXSR1;GCLC;EYA2;SNRK;ENDOV;MARK1;PPA1;BRSK1;STK3;RAP2A;ERN1;TKT;STK11;MTPAP;RHEB;ABL2;IDH3A
prerank,voltage-gated calcium channel activity (GO:0005245),0.3989060467571406,1.07096732230058,0.38717339667458434,0.9561855307574927,1.0,3/37,2.43%,CATSPER4;CACNA2D4;TMC1
prerank,R-SMAD binding (GO:0070412),0.44788917743720047,1.0703468708092618,0.38735177865612647,0.9539417213712381,1.0,5/18,12.33%,DDX5;PMEPA1;SMAD2;MEN1;SMURF1
prerank,transcription coregulator binding (GO:0001221),0.37983632408609164,1.06752857610505,0.38073394495412843,0.9592378018316766,1.0,15/50,18.59%,THAP7;PER2;ZBTB17;TEAD2;CTNNB1;CCNT2;LMO2;RORA;CTCF;NEK6;LCOR;EZH2;PPARD;ZBTB49;CTBP1
prerank,N-acyltransferase activity (GO:0016410),0.40400078346223245,1.0666968240037844,0.3898916967509025,0.957803150854325,1.0,5/32,6.26%,SATL1;SAT1;NAA50;CERS6;SMARCE1
prerank,protein phosphatase 1 binding (GO:0008157),0.43051834318967475,1.0664431391045055,0.3859416445623342,0.9543309487277489,1.0,5/21,15.61%,PPP1R3E;PPP1R3D;AKAP11;PPP1R11;PHACTR4
prerank,I-SMAD binding (GO:0070411),0.4777436079966734,1.0663236162171401,0.4014388489208633,0.9505668297844797,1.0,3/13,12.33%,CTNNB1;SMAD2;SMURF1
prerank,vinculin binding (GO:0017166),-0.40722685011882315,-1.0654556726044158,0.36419753086419754,1.0,1.0,5/11,5.85%,SORBS3;CTNNA1;PXN;DMD;CORO2B
prerank,transcription cis-regulatory region binding (GO:0000976),0.3321741676439345,1.0654236771217822,0.296,0.9493796858848986,1.0,78/406,18.59%,PITX2;SIM1;LHX2;LMX1A;TCF24;TFAP2C;PER2;ZBTB17;ESRRB;NFX1;XRN2;BBX;AGO2;STAT3;ARID5B;ZFP37;RBBP5;RBL1;ELK3;RUNX1;KLF15;CIC;DHX36;MZF1;NFXL1;SOX9;TCF7L2;NFKB1;ZBTB43;CREBRF;TFAP2B;SNAI2;ETV6;SMAD2;ATF6B;CDK5RAP2;TFDP1;NONO;AEBP1;ATF1;TAF2;HMGB1;SCX;RORA;HNRNPL;MEN1;PROX1;NPM1;FOXK1;MAX;CTCF;ZBTB5;TFDP2;XBP1;LONP1;CUX1;KLF10;NR3C1;RB1;ZNF35;CASZ1;SOX2;RREB1;SOX5;MEF2A;TIPARP;SREBF1;ZBED4;ZBTB4;BRD7;POU2F2;ZNF513;DACH1;FOSL2;HDAC1;HINFP;GABPB1;GABPB2
prerank,microtubule plus-end binding (GO:0051010),-0.34688682880364274,-1.0634461581322099,0.3333333333333333,1.0,1.0,11/20,20.17%,STIM1;DST;CLIP1;CLASP2;FBXW11;APC;KIF18A;CLIP3;TTBK2;KNSTRN;CLASP1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.40621285850986,1.0632424697454854,0.4036585365853659,0.9523847125447341,1.0,13/30,29.01%,SLC30A1;SLC30A5;SLC11A2;TTYH1;SLC39A10;SLC39A3;SLC31A1;SLC25A28;SLC39A13;TMEM165;ATP7B;SLC11A1;SLC39A11
prerank,endopeptidase activity (GO:0004175),0.33485779127458526,1.062499577962968,0.3527054108216433,0.9507648291480493,1.0,38/257,16.03%,USP18;CASP4;CASP7;ADAM33;PSMB10;CTSS;PSMA5;PRSS12;ADAMTS3;USP25;MMP14;CASP6;USP15;USP40;PSMA3;CTSC;NLN;ADAMTS19;CTSH;PSMB9;USP34;PCSK7;KLK1;USP14;ADAMTS2;PSEN1;RHBDF2;PREP;PITRM1;NAPSA;MASP1;KDM8;PSMA4;ADAMTS12;USP37;ADAMTS6;HTRA3;SPRTN
prerank,Toll-like receptor binding (GO:0035325),0.4873595532873082,1.0615924399951249,0.40955137481910275,0.949494103143763,1.0,3/11,15.56%,UNC93B1;MYD88;TLR2
prerank,SH2 domain binding (GO:0042169),0.3988859836522004,1.0614069470679026,0.3882063882063882,0.9460240799044567,1.0,11/31,20.63%,SLAMF1;IRS1;CCDC88A;TRPV4;RACK1;JAK2;CRK;BLNK;SH3PXD2B;PAG1;LCK
prerank,retinoic acid receptor binding (GO:0042974),0.4460087559068095,1.0594813180994105,0.4092140921409214,0.9486152072272062,1.0,3/17,11.00%,PRMT2;RARG;SNW1
prerank,GTPase regulator activity (GO:0030695),0.3382644582173658,1.05943771423926,0.3628140703517588,0.9446542107021412,1.0,66/212,20.41%,WNT11;RASA4;RGPD1;TBC1D1;TAGAP;THY1;SYDE1;TBC1D8;AGAP2;RAPGEF2;CCDC88A;ABR;SEC23A;CDC42SE1;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;ARHGAP25;STARD8;HACD3;SRGAP2;RIN2;SOS1;ARHGAP10;RGS16;CHN1;SIPA1L1;ARHGAP11A;ALDH1A1;NRP1;ARHGAP39;RANBP1;ARHGAP30;SMAP1;RANBP3L;ASAP3;TBCD;SH3BP1;LLGL1;OPHN1;TBCK;STXBP5L;ARL2BP;OCRL;BCR;RUNDC3A;TBC1D2;RALGAPB;ARHGAP29;NF1;CPEB2;SIPA1L3;NPRL2;ARAP1;NPRL3;ARHGAP24;EIF5;ARHGAP42;ARHGAP18;SGSM1;TBC1D4;SGSM3;SIRPA;RGS10;ARHGAP31
prerank,cation channel activity (GO:0005261),0.35395804220866345,1.0592766023260238,0.40274841437632136,0.9411574455094491,1.0,15/94,15.96%,TRPM5;TRPM2;TRPM6;CUL5;TMEM38A;CALHM6;TRPM3;PANX1;ANO10;KCNK3;PSEN1;TRPV4;TMEM38B;TRPM7;SLC24A3
prerank,kinase binding (GO:0019900),0.3304689971635628,1.0587655991518763,0.325,0.9388446048558049,1.0,143/434,26.03%,SP100;IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;SOCS1;DAXX;ZFP36;UTRN;CHEK2;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;RHOF;CCND2;HSP90AB1;DUSP3;CDKN2D;CACUL1;CTNNB1;CCND1;FAM83H;PFKM;AP2A1;ARHGEF7;CAB39;TCF7L2;USF1;PIP5K1A;DOK7;MAP2K3;CYLD;MAPRE1;AGAP2;CNTLN;MTCP1;CDK5RAP2;BCAR1;CSPG4;BARD1;CNKSR2;SIKE1;NEK9;PRKAG1;UBQLN1;MOB1B;NPM1;CEP152;IRAK4;SIK1;GSN;NEK6;STAP1;RELB;PTPN11;NR3C1;RB1;TRPV4;RPS6;LIMS1;BAD;TELO2;LYST;ACTB;RAC1;IFNAR2;SNAP91;DLG1;JAK2;RB1CC1;TNIP2;USP37;CALM3;ERCC6L2;CRK;OXSR1;LLGL1;NBEA;IRAK1;CCNK;BLNK;ZBTB4;TRIP4;SPRED3;PTPRC;CDC37;MIDN;SPRED1;RFFL;BECN1;PER1;ACVRL1;PPP2R5A;RND2;ANKRA2;LCK;CADPS;ADIPOR1;GADD45A;RHOH;CKS2;TRIP6;PRKCD;STUB1;TOM1L2;PRDX3;MSN;GPRC5B;MAPRE3;RAD9A;PPP1R12A;IRF5;SYN1;AXIN1;KAT2B;FLNA;ACSL3;EXOC2;PTPN6;PRKAB2;CALM2;ANK2;PTPN23;TUBA4A;CEP192;DCTN1;CDKN2A;WDCP;PTPN1;PIH1D1;RAD23A;SHC1;CHP1;FERMT2;ADD2;CAV2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.491013116396394,1.057687414831656,0.4158125915080527,0.9383796043182299,1.0,3/11,26.98%,SLC25A47;SLC25A45;SLC22A4
prerank,protein serine/threonine kinase activity (GO:0004674),0.3316706548253359,1.056726584761387,0.3396793587174349,0.9373854244091593,1.0,93/334,22.50%,EIF2AK2;PKMYT1;TAOK3;DAPK3;SRPK3;SGK2;SGK3;CAMK2D;TP53RK;ALPK1;FASTK;CPNE3;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;MAP3K8;STK38L;PKN2;PNCK;CHEK1;IKBKE;CDK12;MKNK1;PAK3;NRBP2;CSNK2B;CSNK2A2;HTATIP2;VRK3;CLK3;PIK3R4;SRPK1;PLK3;MAST3;MAPK14;BMPR2;CDK19;TNIK;RIOK3;CDK10;NUAK2;CDK20;BCKDK;IRAK4;SIK1;PIM1;DYRK2;NEK6;PRKDC;PRKCE;CLK2;MAP3K4;PRKCH;MINK1;FAM20C;MASTL;BMPR1A;NRBP1;TAOK2;OXSR1;MTOR;IRAK1;CCNK;PHKG2;STK39;BCR;SNRK;ACVR2A;MARK1;BRSK1;TESK1;MAP3K15;NEK7;STK24;STK3;STK16;AAK1;ERN1;RIPK2;ACVRL1;TLK2;STK11;MAP4K2;CDK9;SBK1;PRKCD;MAPK9;AKT3;PIM3;CDK8;CDK16
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.37920985595322276,1.0532879373758421,0.4029680365296804,0.9446691307407961,1.0,16/44,22.85%,RBBP5;KMT2A;NSD3;SETD3;ASH1L;MEN1;WDR5;SETD5;SETDB2;EZH2;SMYD1;SMYD2;SMYD5;SETD7;KMT5C;KMT2D
prerank,GTPase activator activity (GO:0005096),0.3312470958237834,1.05291031069137,0.35005015045135407,0.9419334261707873,1.0,94/313,20.47%,WNT11;RASA4;DOCK8;RGPD1;RGP1;TBC1D1;RINL;TAGAP;SPATA13;THY1;SYDE1;SBF1;RCC1L;ARHGEF7;HERC2;TBC1D8;DENND1A;GAPVD1;RAPGEF6;AGAP2;RAPGEF2;CCDC88A;ABR;EIF2B2;SEC23A;RAP1GAP;SYDE2;VAV1;SIPA1L2;TBC1D8B;ARHGAP25;STARD8;ANKRD27;ARHGEF11;HACD3;SRGAP2;RIN2;ARHGEF10;SOS1;ARHGAP10;FGD6;LAMTOR3;ARFGEF2;RGS16;CHN1;SIPA1L1;ARHGAP11A;ALDH1A1;RIC1;RAPGEF1;AKAP13;IQSEC2;NRP1;ARHGAP39;RANBP1;ARHGAP30;SMAP1;RANBP3L;ASAP3;DENND10;MYCBP2;DENND6B;TBCD;SH3BP1;LLGL1;OPHN1;TBCK;DENND4A;STXBP5L;OCRL;BCR;TBC1D2;WDR41;PLCE1;RALGAPB;ARHGAP29;NF1;EIF2B5;SIPA1L3;EIF2B3;NPRL2;ARAP1;NPRL3;ARHGAP24;DENND1B;ARHGAP42;ARHGAP18;SGSM1;TBC1D4;SGSM3;RGS10;ARHGAP31;LAMTOR4;DOCK10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4852746426806692,1.0516417872093096,0.413986013986014,0.9420967098965537,1.0,5/11,25.24%,PRMT2;PRMT1;PRMT3;FBXO11;PRMT9
prerank,hormone activity (GO:0005179),0.3697230389215689,1.0515489757957568,0.4125560538116592,0.9384696519011299,1.0,2/54,0.65%,GAL;AGT
prerank,lysophospholipase activity (GO:0004622),-0.3402827881257352,-1.0511841925987613,0.37050359712230213,1.0,1.0,5/20,13.52%,ABHD16A;LYPLA1;LYPLAL1;MGLL;ABHD12
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.49010581063559916,1.050232150171027,0.4258720930232558,0.9388199729065675,1.0,5/11,17.91%,DCP2;NUDT5;NUDT16;NUDT4;DCPS
prerank,NADPH binding (GO:0070402),0.4741313766621921,1.0477842468605179,0.44244105409153955,0.9426503207620032,1.0,2/13,1.99%,DHFR;GRHPR
prerank,transaminase activity (GO:0008483),0.48225977425376515,1.0476163503753242,0.4094955489614243,0.939322539643072,1.0,1/11,0.65%,AGXT
prerank,protein tyrosine kinase binding (GO:1990782),0.3479510508544703,1.0470888420767441,0.41352549889135254,0.937191659463497,1.0,16/71,16.54%,CPNE3;ACVR1;ELMO2;DUSP3;PITPNM1;EPHA4;NCK1;SOCS5;BMPR2;PRR7;PTPN11;TJP2;RACK1;HSP90AA1;CRK;BLNK
prerank,triglyceride lipase activity (GO:0004806),0.4219944644349514,1.0449544188750741,0.41830065359477125,0.94015925857639,1.0,2/20,7.75%,PNPLA2;LIPC
prerank,calcium ion binding (GO:0005509),0.3272586659737514,1.0447659585434592,0.3817635270541082,0.9368655539513027,1.0,53/323,17.28%,NOL3;CABP4;LOXL2;AOAH;ASPH;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;ENPP3;CABYR;ITPR1;TNNC1;PITPNM1;SYT7;RET;AIF1L;FBN1;CDH9;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;PRNP;AGRN;CIB1;CRACR2A;ADGRV1;NOTCH4;SLIT3;SLIT1;GSN;ENPP1;CAPN1;MICU2;MASP1;DNER;SLC25A12;PAM;CALM3;ACER3;AIF1;RPH3A;PCDHA4;PCP4;SPARCL1;ANXA4
prerank,calcium channel activity (GO:0005262),0.35275029353696435,1.0444509075958048,0.4200426439232409,0.9340457776127942,1.0,13/84,15.96%,TRPM5;CATSPER4;TRPM2;CACNA2D4;TMC1;CUL5;CACNA1A;P2RX4;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,proton transmembrane transporter activity (GO:0015078),0.3828243330340094,1.0440227695719375,0.42873563218390803,0.9317643144978885,1.0,8/39,17.44%,UQCRQ;MFSD3;SLC46A1;SLC11A2;DMAC2L;UQCR10;CTNS;ATP6V1B2
prerank,carbohydrate kinase activity (GO:0019200),0.49218136314301225,1.0424807136800944,0.4412191582002903,0.9329478052831972,1.0,4/11,14.22%,HK1;FGGY;GNE;GALK2
prerank,"DNA binding, bending (GO:0008301)",0.4538259479293277,1.04238527344831,0.4177215189873418,0.9294901504618732,1.0,3/14,11.87%,SAP30L;HMGB1;HMGB3
prerank,myosin binding (GO:0017022),0.3587704019680603,1.0407339588041722,0.411697247706422,0.9309952191220348,1.0,13/55,16.42%,CXCR4;TRAK1;MYOC;RAB11B;SPATA6;RAB14;GSN;MYRIP;MOBP;NCKIPSD;LLGL1;RAB11A;STXBP5L
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.34098699912290376,-1.040375616299416,0.38113207547169814,1.0,1.0,5/18,10.82%,AKR1B1;ALDH2;ALDH18A1;ALDH3B1;FAR1
prerank,fatty acid synthase activity (GO:0004312),0.496854450739976,1.0398069505605494,0.4394409937888199,0.9302314747773471,1.0,1/10,0.51%,MCAT
prerank,pyrophosphatase activity (GO:0016462),0.37044671494407755,1.0389744891963315,0.43498273878020716,0.9290896761731312,1.0,17/50,22.66%,TRPM2;ENTPD3;ENPP3;ENTPD6;DCP2;DHX9;NUDT5;ENTPD5;ENPP1;NUDT16;NUDT4;DCPS;PPA1;DDX3X;LHPP;ENTPD7;DOLPP1
prerank,cholesterol binding (GO:0015485),0.3660674762649828,1.0387847526744278,0.425947187141217,0.9260077257670648,1.0,15/47,16.64%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;STARD3;TSPO;PTCH1;NPC1;ERLIN2;OSBP2;NPC2;GRAMD1C;SOAT2;SOAT1
prerank,adenylate cyclase binding (GO:0008179),0.48225314894894167,1.0386859624839655,0.41706161137440756,0.9227373453965235,1.0,3/10,15.26%,ADCY5;AKAP12;CALM3
prerank,protein kinase binding (GO:0019901),0.32432017799337964,1.0375738587023502,0.386,0.9223374471934033,1.0,107/479,17.53%,IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;IRS1;SOCS1;DAXX;ZFP36;UTRN;CHEK2;NELL2;ACVR1;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;RHOF;MAD2L2;CCND2;DUSP3;CDKN2D;CACUL1;SOX9;CCND1;FAM83H;AP2A1;EPHA4;ARHGEF7;TCF7L2;USF1;DOK7;MAP2K3;NBR1;CYLD;MAPRE1;AGAP2;CNTLN;MTCP1;MAPK8IP3;CDK5RAP2;CCDC88A;DACT1;BCAR1;CSPG4;PRKAR2B;ROR2;CNKSR2;SIKE1;BMPR2;NEK9;PRKAG1;TNIP1;GCH1;PRR7;NPM1;CEP152;IRAK4;SIK1;NEK6;STAP1;RELB;PTPN11;NR3C1;TJP2;DUSP10;TRPV4;RPS6;RACK1;LIMS1;BAD;DUSP16;NELL1;TELO2;LYST;ACTB;RAC1;IFNAR2;SNAP91;DLG1;JAK2;RB1CC1;HSP90AA1;TNIP2;USP37;CALM3;ERCC6L2;CRK;SPAG9;TAOK2;OXSR1;LLGL1;NBEA;IRAK1;CCNK;BLNK;ZBTB4;PRKAR2A;CSK;TRIP4;SPRED3;PTPRC
prerank,iron ion binding (GO:0005506),0.37245984125429604,1.0375213272979493,0.4300341296928328,0.9189197317242114,1.0,11/48,17.02%,ETHE1;FXN;EGLN2;NFU1;ALKBH1;ABCE1;SCD5;ALKBH2;TET2;KDM7A;FBXL5
prerank,glycerophospholipid flippase activity (GO:0140333),0.48092622704841387,1.0371587697121007,0.4406015037593985,0.9165117600165036,1.0,2/11,4.37%,ATP10A;ATP8A1
prerank,semaphorin receptor binding (GO:0030215),-0.3055659250450281,-1.0360746191958576,0.35323383084577115,1.0,1.0,13/23,28.97%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,sequence-specific DNA binding (GO:0043565),0.32100295978552623,1.034686803591866,0.359,0.9206270598370657,1.0,96/590,17.01%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;MYBBP1A;TFAP2C;GMEB2;LRWD1;ESRRB;RARG;BBX;TEAD2;ZBTB2;NFKB2;MECP2;BATF3;ELK3;SMG7;BHLHE40;NKX6-2;KLF15;JUNB;ZNF23;SOX9;KMT2A;ZNF76;MBD2;BCL6;TCF7L2;TCF4;ZBTB43;ZBTB38;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;MEIS3;ATF6B;SLTM;NFIB;HOXA9;POU3F1;SCX;RORA;ELF4;IRF9;BPTF;NR2C1;PROX1;FOXK1;MAX;CTCF;XBP1;LONP1;SMG5;CUX1;KLF10;ZNF423;TEF;NR3C1;PPARGC1A;UPF2;HOXB6;UPF3A;FBXL19;PRDM4;ZNF35;E2F4;CXXC4;CHTOP;TELO2;STN1;ZBTB21;BCL11B;SOX2;MBNL2;CREB5;POU6F1;ERF;KLF16;MEF2A;ZCWPW1;PRMT1;PPARD;SREBF1;UPF1;ZBTB4;RBPJ;ELF1;HMBOX1;CHCHD2
prerank,acid-thiol ligase activity (GO:0016878),-0.37959152709534694,-1.0335303617567948,0.4240506329113924,1.0,1.0,5/13,21.71%,ACSS3;AACS;ACSL1;ACSS1;SLC27A2
prerank,phospholipase activity (GO:0004620),-0.24547274684204526,-1.0327936706031648,0.3541666666666667,1.0,1.0,21/67,21.63%,PLCB2;ABHD16A;LYPLA1;PLAAT3;NAPEPLD;LIPH;SMPDL3A;SMPD3;LYPLAL1;PDIA3;PLBD1;PITPNM3;MGLL;ABHD12;LPL;PLD4;SEC23IP;PLA2G15;SMPD1;ABHD6;SMPD2
prerank,phosphatase activator activity (GO:0019211),0.44756041070926417,1.032134130430924,0.43786127167630057,0.9250883885565634,1.0,6/14,24.61%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.35054223371872245,1.030938130909151,0.44360902255639095,0.9254239427922452,1.0,26/69,27.26%,LIPT1;MCAT;ZDHHC21;ZDHHC20;CERS6;HHAT;LPGAT1;SOAT2;SOAT1;KAT8;ZDHHC13;ZDHHC8;CERS2;PLA2G4E;ZDHHC3;DBT;NMT1;ZDHHC18;KAT6A;KAT2B;AWAT2;ZDHHC17;ZDHHC16;PLA2G4A;EP300;ZDHHC7
prerank,lipoprotein particle binding (GO:0071813),0.42376921906503684,1.0293365381172435,0.43483870967741933,0.9266978446308034,1.0,6/20,20.93%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,actin monomer binding (GO:0003785),-0.31380693951294897,-1.026359963181524,0.41409691629955947,1.0,1.0,4/22,9.48%,MTSS1;COBL;CORO1A;TMSB10
prerank,androgen receptor binding (GO:0050681),0.4053132550008226,1.0262138445664386,0.4535175879396985,0.9326176016873624,1.0,3/25,3.56%,DAXX;PRMT2;DDX5
prerank,1-phosphatidylinositol binding (GO:0005545),0.45064917920801484,1.0241932458931742,0.4476584022038568,0.9352649620509236,1.0,7/15,24.21%,SNX10;WDFY1;SNX9;SNAP91;ZFYVE1;EEA1;WDFY3
prerank,carboxypeptidase activity (GO:0004180),-0.29159628904917234,-1.0209174393259373,0.36363636363636365,1.0,1.0,9/35,15.92%,AGBL4;BLMH;CTSA;AGTPBP1;AGBL5;AGBL3;CTSZ;CPE;CPA6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4740659857779799,1.0194270970971637,0.4635958395245171,0.9462414979654759,1.0,3/11,11.05%,RDH14;RDH11;AKR1B10
prerank,estrogen receptor binding (GO:0030331),0.37400178132515505,1.0181395686217978,0.44938271604938274,0.9465181401654891,1.0,9/32,23.96%,PRMT2;NCOA1;CTNNB1;LCOR;DDX54;TRIP4;CCDC62;NRIP1;TACC1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3152255906799551,1.017679863463984,0.45,0.9443178357153872,1.0,78/597,13.03%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;TFAP2C;PER2;GMEB2;MCM2;ESRRB;RARG;BBX;DHX33;TEAD2;ZBTB2;NFKB2;STAT3;ARID5B;BATF3;RBBP5;ELK3;RUNX1;MCM7;BHLHE40;NKX6-2;KLF15;DHX36;MZF1;JUNB;MCM4;ZNF23;SOX9;KIF2C;ZNF76;MBD2;BCL6;TCF7L2;TCF4;NFKB1;ZBTB43;MCM9;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;DHX9;MEIS3;ATF6B;CDK5RAP2;NONO;NFIB;HOXA9;TAF2;POU3F1;HMGB1;ELF4;IRF9;HNRNPL;MEN1;NR2C1;PROX1;FOXK1;MAX;CTCF;XBP1;CUX1;KLF10;TEF;NR3C1;ORC3;HOXB6;DDX11;PRDM4;E2F4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4018413672476742,-1.0155903724353252,0.4375,1.0,1.0,5/10,17.58%,DPP8;DPP4;DPP7;DPP9;FAP
prerank,heme binding (GO:0020037),0.3485675827545526,1.013950004390687,0.4604236343366778,0.951954526140161,1.0,13/65,18.23%,PXDNL;CYBB;THAP4;BACH1;CYB5B;CYP26B1;CYP27A1;CYB561D1;JAK2;PTGES2;HMOX2;PGRMC1;FLVCR1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3859219947852607,-1.0131659328312064,0.4166666666666667,1.0,1.0,3/11,11.82%,MAP3K20;EGFR;MAP3K13
prerank,hyaluronic acid binding (GO:0005540),0.4760209331401719,1.0125418180142616,0.47023809523809523,0.9526365378860151,1.0,2/10,8.24%,STAB2;IMPG2
prerank,death receptor activity (GO:0005035),-0.40170529460476373,-1.011872667004733,0.43506493506493504,1.0,1.0,8/11,47.96%,TNFRSF1B;TNFRSF19;FAS;TNFRSF25;TNFRSF4;NGFR;TNFRSF1A;EDA2R
prerank,peptidase activator activity (GO:0016504),0.3959109769964597,1.0106426215807525,0.45430809399477806,0.9548099581397279,1.0,10/22,25.56%,PSME2;PSME4;PSME3;APH1A;APH1B;PCOLCE;TANK;ADRM1;VCP;PSENEN
prerank,potassium:proton antiporter activity (GO:0015386),-0.4103173229280804,-1.0105588358794484,0.40978593272171254,1.0,1.0,1/10,1.06%,SLC9A9
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.34040708379648943,-1.0105300036377083,0.43973941368078173,1.0,1.0,6/16,16.37%,INPP5F;MTMR4;MTMR1;MTMR9;MTMR10;MTM1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.34390260920002774,1.0103821967328528,0.47110141766630315,0.9520755504564455,1.0,12/75,12.70%,SORD;GRHPR;HSD17B7;PHGDH;PGD;PTGR1;DHRS4;RDH11;LDHD;AKR1B10;DHRS11;LDHB
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3123967976081546,1.0082029918389448,0.452,0.955201539385065,1.0,110/731,16.06%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;NACC1;BHLHE40;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;BCL6;TCF7L2;TCF4;NFKB1;ZBTB38;BACH1;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;DHX9;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;NFIB;ATF1;HOXA9;POU3F1;SCX;DACH2;RORA;ELF4;IRF9;ZSCAN20;BPTF;NR2C1;PROX1;FOXK1;MAX;CTCF;ZBTB5;XBP1;MITF;SKIL;KLF10;ZNF423;RELB;TEF;NR3C1;REL;HOXB6;PRDM4;E2F4;PGBD1;ST18;IKZF1;BCL11B;ZNF418;MYPOP;SOX2;RREB1;MYB;CREB5;ZBTB34;POU6F1;ZBTB24;SOX5;KLF16;GTF2IRD1;MEF2A;CARF;PPARD;PROX2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3118623408849463,1.0067055741939435,0.451,0.9562063770103297,1.0,109/732,16.06%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;NACC1;BHLHE40;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;BCL6;TCF7L2;TCF4;NFKB1;ZBTB38;BACH1;ZSCAN29;USF1;TFAP2B;NFATC2;SNAI2;UBP1;SRF;DHX9;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;NFIB;ATF1;HOXA9;POU3F1;DACH2;RORA;ELF4;IRF9;ZSCAN20;BPTF;NR2C1;PROX1;FOXK1;CTCF;ZBTB5;XBP1;MITF;SKIL;KLF10;ZNF423;RELB;TEF;NR3C1;REL;HOXB6;PRDM4;E2F4;PGBD1;ST18;IKZF1;BCL11B;ZNF418;MYPOP;SOX2;RREB1;MYB;CREB5;ZBTB34;POU6F1;ZBTB24;SOX5;KLF16;GTF2IRD1;MEF2A;CARF;PPARD;TIPARP;PROX2
prerank,sodium:proton antiporter activity (GO:0015385),-0.39303216631832755,-1.006273173706685,0.43558282208588955,1.0,1.0,3/11,23.78%,SLC9A9;SLC9A8;SLC9B2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.37429203713551373,-1.0058839129366364,0.4276315789473684,1.0,1.0,5/12,20.81%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5
prerank,metal ion binding (GO:0046872),0.31322762534229553,1.0038170833022015,0.492,0.9614298633393794,1.0,109/477,21.89%,NOL3;CABP4;LOXL2;AOAH;XYLT2;ASPH;MSH2;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;STK38L;ENPP3;CABYR;ITPR1;DHX36;TNNC1;RRAGC;PITPNM1;PDXP;MT3;NT5C3A;HMGCL;SYT7;RET;IDH1;AIF1L;NUDT5;FBN1;CDH9;FEN1;PGM1;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;UBA2;SRPK1;PRNP;AGRN;CIB1;CRACR2A;NUAK2;ADGRV1;HPRT1;NOTCH4;XXYLT1;SLIT3;SLIT1;SIK1;DYRK2;GSN;NEK6;TRIM26;EPHX2;APOE;ENPP1;CAPN1;PAPOLA;MICU2;MASP1;DIS3L2;DNER;SLC25A12;GEN1;PAM;CALM3;NUDT16;TDG;ACER3;OXSR1;AIF1;RPH3A;GCLC;EYA2;PCDHA4;PCP4;SPARCL1;ANXA4;SNRK;MAN1C1;ENDOV;MARK1;PPA1;BRSK1;STK3;CAMKK2;RAP2A;ERN1;PLA2G4E;TGM2;RPE;EFHD2;TKT;TPD52;SPARC;STK11;MTPAP;MCTP1;RHEB;ABL2;ARSA;S100A13
prerank,insulin-like growth factor binding (GO:0005520),-0.35067307158187505,-1.003414319475055,0.4072727272727273,1.0,1.0,9/15,24.33%,ITGAV;IGF2R;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,endodeoxyribonuclease activity (GO:0004520),0.40735270212888564,1.0011745735347892,0.4747340425531915,0.966150407488667,1.0,6/20,19.73%,APLF;FEN1;ERCC4;ZRANB3;ENDOV;DCLRE1C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.44812756336092063,0.9995116930597296,0.484984984984985,0.967797702942476,1.0,3/13,13.11%,PIK3CD;PIP5K1A;PIK3CB
prerank,transcription corepressor binding (GO:0001222),0.3853514134809401,0.9949399465653652,0.4796547472256473,0.9773356302356541,1.0,8/27,20.07%,THAP7;PER2;RORA;NEK6;LCOR;EZH2;CTBP1;PER1
prerank,endopeptidase regulator activity (GO:0061135),0.3624413358056401,0.9947445162825657,0.46904761904761905,0.9743462008931957,1.0,8/40,15.36%,PSME2;SLPI;UCHL5;CST7;USP14;PSME3;APH1A;APH1B
prerank,chemokine binding (GO:0019956),0.3817157225104678,0.9922525064073656,0.48951911220715166,0.9780068671076534,1.0,5/30,9.06%,CXCR4;ZFP36;ACKR3;HMGB1;PDPN
prerank,C-C chemokine binding (GO:0019957),0.4036966357610722,0.9918839459758334,0.4968152866242038,0.9756866638021331,1.0,3/22,8.51%,CXCR4;ZFP36;ACKR3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35891911857947284,0.9905469550306037,0.4929906542056075,0.9762623748911052,1.0,17/42,25.72%,IRS1;HCK;FBXW7;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;PIN1;LCK;YES1;ABL2;PTPN6;YWHAE;SHC1
prerank,ligand-gated anion channel activity (GO:0099095),-0.3270673336637577,-0.9901214551334648,0.4620938628158845,1.0,1.0,6/17,15.63%,GABRG3;GABRB1;GLRB;GABRA2;GLRA3;GABRB3
prerank,hormone receptor binding (GO:0051427),0.4364431529951272,0.9887357733690978,0.4782608695652174,0.9780890467770251,1.0,5/14,24.41%,NPPC;SOCS2;JAK2;CCK;JAK1
prerank,carboxylic acid binding (GO:0031406),-0.2614994468584032,-0.987915609559046,0.504,1.0,1.0,8/38,11.77%,GRIN2B;SRR;GRIN1;GLRB;CASTOR2;HIF1AN;EPDR1;GLRA3
prerank,amino acid:sodium symporter activity (GO:0005283),0.4647391258206497,0.9877309296226859,0.5042613636363636,0.9774811096760418,1.0,2/11,3.44%,SLC38A2;SLC38A1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.26999201311431525,-0.98524864427888,0.4318181818181818,1.0,1.0,7/35,11.62%,SYK;SLA;DYRK1A;FES;FGR;SRC;TNK2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4546246796992328,0.9840587711992027,0.4940119760479042,0.9846320216799869,1.0,5/12,21.88%,PDE7B;PDE8B;PDE3A;PDE4B;PDE4A
prerank,U6 snRNA binding (GO:0017070),-0.36179385323525204,-0.98404081949579,0.4539249146757679,1.0,1.0,6/14,22.72%,METTL16;LARP7;LSM3;LSM2;TUT1;RBM22
prerank,metalloexopeptidase activity (GO:0008235),0.3424798735564936,0.9836263994116259,0.5063291139240507,0.982343633988544,1.0,14/51,24.07%,LAP3;MMP14;AGBL2;ERAP1;CPQ;AEBP1;NPEPPS;NUDT16;METAP2;FOLH1;MMP15;TRHDE;VASH1;RNPEP
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2694564330637535,-0.9834214944987031,0.4896907216494845,1.0,1.0,10/35,16.11%,APEX2;PLCB2;MPPED2;NAPEPLD;SMPDL3A;SMPD3;PDIA3;PLD4;GPCPD1;SMPDL3B
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.37989014797767306,0.9810879550644377,0.5101265822784811,0.9863302342350495,1.0,2/28,2.43%,CHRNA9;GRIK3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3558152040725109,-0.9806078759175698,0.4489051094890511,1.0,1.0,5/14,15.05%,MICAL1;NOX1;AIFM1;NCF2;KMO
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3747305729686641,0.9796218260383659,0.5126262626262627,0.987052849501077,1.0,11/28,23.01%,AGO2;RNASEH2A;FEN1;DBR1;NUDT16;DICER1;RPP30;ENDOV;RPP14;RNASEH1;RPP21
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3991406141678678,0.9779826799083422,0.4961340206185567,0.9882925502898723,1.0,8/22,21.23%,PARP10;IKBKE;ZRANB3;ZRANB1;SPRTN;TAB3;ATRIP;OPTN
prerank,neuropeptide hormone activity (GO:0005184),0.3937547470462277,0.9779441295851671,0.5057915057915058,0.9849967331452616,1.0,1/22,0.59%,GAL
prerank,transmitter-gated ion channel activity (GO:0022824),0.3698829497533923,0.9764147624584557,0.486318407960199,0.9859810136918324,1.0,12/29,25.21%,GRIN2D;GRIK3;GRIA2;GLRA2;GRID1;GRIA4;GABRG1;GABRB2;GRIK4;GABRA3;GRIK2;GRIK5
prerank,copper ion binding (GO:0005507),0.3536597404398991,0.9731500267460816,0.5188235294117647,0.9918691381138689,1.0,13/42,25.64%,LOXL2;MT3;P2RX4;PRNP;PAM;LACC1;COX17;SUMF1;S100A13;CUTA;ANG;COMMD1;ATP7B
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.37403834113166096,-0.9730544393529642,0.48859934853420195,1.0,1.0,4/12,16.51%,ARSB;SULF1;ARSK;SGSH
prerank,carboxy-lyase activity (GO:0016831),0.3878348240192743,0.9726867676310487,0.5062189054726368,0.9897754687685705,1.0,6/23,18.12%,AZIN2;DDC;AZIN1;GGCX;ACOD1;GAD1
prerank,sterol binding (GO:0032934),0.33645273235916723,0.9709361065674159,0.5335608646188851,0.9911837156549718,1.0,18/56,16.64%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;RORA;STARD3;TSPO;PTCH1;NPC1;OSBPL9;ERLIN2;OSBP2;NPC2;GRAMD1C;OSBP;SOAT2;SOAT1
prerank,protease binding (GO:0002020),0.3168258883112613,0.9658977406794,0.567398119122257,1.0,1.0,32/99,25.72%,NOL3;COMP;SERPINC1;BFAR;LONP2;CFLAR;ITGA3;AMFR;PRNP;TWNK;TIMP2;RIOK3;COL3A1;CHMP3;LCOR;TRIP4;CRADD;LDLR;RFFL;NFRKB;RIPK2;F3;ADRM1;SART3;POLG;SUMO1;INSL3;VCP;ANXA2;TNF;DERL2;RAD23A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3682313826895378,0.9656689543570565,0.5262515262515263,0.9990513777142203,1.0,8/33,12.98%,AUP1;RNF5;SIAH1;DCUN1D4;RNF19B;UBA2;ARIH1;RNF185
prerank,nucleosomal DNA binding (GO:0031492),0.3878793329533081,0.9645862957826465,0.5305591677503251,0.9988658458439605,1.0,9/21,24.04%,MBD2;SMARCC2;SMARCE1;MTA2;ACTB;SMARCD2;HDAC1;HDAC2;ACTL6A
prerank,phosphatidic acid binding (GO:0070300),0.40459229324267265,0.963973382506721,0.4986559139784946,0.9972694832932759,1.0,4/19,8.09%,PLEKHN1;PITPNM1;RAPGEF6;RAPGEF2
prerank,retinoic acid binding (GO:0001972),-0.36466052665767823,-0.9635829933304026,0.49843260188087773,1.0,1.0,3/12,12.18%,RXRA;RARA;NR2F2
prerank,tRNA binding (GO:0000049),-0.25608214204584867,-0.9634106317497825,0.45384615384615384,1.0,1.0,12/43,13.76%,FARS2;EEF1A1;EIF2A;TYW5;PSTK;TRNT1;MRPS27;TRMT10B;RPUSD4;YRDC;TRMT10A;NEMF
prerank,voltage-gated potassium channel activity (GO:0005249),-0.22111801054904587,-0.9623489866133189,0.5970149253731343,1.0,1.0,37/80,40.49%,KCNC2;KCNH1;KCNJ10;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNA2;KCNC3;KCNG2;KCNC1;KCNT2;KCNT1;KCNJ6;KCNJ13;KCNB2;HCN3;KCNH5;KCNC4;KCNH2;KCNQ4;KCNJ12;HCN4;LRRC55;KCNJ16;KCNH4;KCNN1;KCNQ1;KCNIP2;KCNG1;KCNE3;KCNJ15;KCNG4;KCNA6;KCNE4;KCNG3
prerank,nuclear localization sequence binding (GO:0008139),0.4041420645761855,0.9619203611872673,0.5365853658536586,0.9994458987717095,1.0,3/18,4.83%,RANBP6;NUP153;KPNB1
prerank,rRNA binding (GO:0019843),0.3484990600094924,0.9604644535707962,0.541813898704358,1.0,1.0,8/42,7.17%,SBDS;ERAL1;NOP53;NGRN;RCC1L;MRPL16;RRS1;PPAN
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3274945313659159,0.9595027154543587,0.5635775862068966,0.9994488049891771,1.0,27/71,27.24%,EYA4;CDC25B;PTPN18;DUSP3;TIMM50;PTPN7;DUSP26;PTPN11;DUSP11;PTPN9;EYA2;PTPRU;PTPRC;PTPRB;PTPRF;PTP4A2;PTPRM;PTPN6;PTPRS;PTPN23;PTPN1;EYA3;PTEN;EYA1;CDC14A;PTPRN;PTPRE
prerank,glucuronosyltransferase activity (GO:0015020),0.3970160017772051,0.9586857966426183,0.5412234042553191,0.9983372908836902,1.0,1/19,0.70%,EXT1
prerank,nuclear import signal receptor activity (GO:0061608),0.41138775202154193,0.9570901604137715,0.53954802259887,0.9991908678458364,1.0,3/15,13.53%,RANBP6;KPNB1;TNPO2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4299602789994072,0.9568690923358831,0.5205278592375366,0.9964738626266897,1.0,7/12,28.71%,IRS1;STAP1;BLNK;GAB2;SHC1;SH2B1;PIK3R1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3528953479369959,0.9566775675625409,0.539568345323741,0.9936973422072515,1.0,11/38,16.54%,IRS1;MAGI2;MAPK8IP3;NCK1;NCK2;LDLRAP1;G3BP2;STAP1;PTPN11;SPAG9;BLNK
prerank,SUMO transferase activity (GO:0019789),0.4109580584304194,0.9562748905544449,0.5433287482806052,0.9915359978841037,1.0,8/16,27.91%,CBX4;NSMCE2;PIAS1;PIAS2;HDAC4;TRIM28;PIAS4;RANBP2
prerank,FAD binding (GO:0071949),0.38010875328968197,0.9554164437165739,0.5265200517464425,0.9905554174387541,1.0,3/24,8.06%,MTHFR;CYB5R2;CYB5R3
prerank,steroid hydroxylase activity (GO:0008395),0.4051343845535535,0.9551055225846042,0.5197278911564626,0.9881151838163279,1.0,3/16,20.69%,CH25H;CYP27A1;CYP39A1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.41465670921535086,0.9545687807631505,0.5340909090909091,0.986364977989778,1.0,3/14,11.42%,SLC26A1;SLC25A10;SLC26A2
prerank,ion gated channel activity (GO:0022839),0.3732297968097834,0.9531798408944865,0.5372945638432364,0.9868341013545943,1.0,4/24,16.31%,TRPM5;TTYH1;ANO10;ANO5
prerank,protein kinase inhibitor activity (GO:0004860),0.34469855333979693,0.9517760699261293,0.5385487528344671,0.9872210060901505,1.0,9/42,13.93%,TAOK3;SPRY2;SOCS1;GMFB;NCK1;CIB1;NPM1;RACK1;DUS2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.35229136308457554,0.9514013242726316,0.5504926108374384,0.9851057386704911,1.0,10/37,18.10%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;YARS2;TARS2
prerank,protein tyrosine kinase activity (GO:0004713),0.3078207925816273,0.949768331511676,0.5666666666666667,0.9862235334392778,1.0,30/108,23.28%,AXL;FLT1;KDR;HCK;PEAK1;EPHA4;FGFR2;RET;EPHA6;LTK;LYN;MET;ROR2;INSR;DYRK2;FYN;JAK2;FGFR3;CSK;CAMKK2;WEE1;DDR2;LCK;YES1;ROR1;ABL2;ERBB3;TWF1;PKDCC;AATK
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3586419919953658,-0.9481574189000316,0.5143769968051118,1.0,1.0,2/11,3.56%,PPP1R14C;PPP1R8
prerank,phosphotyrosine residue binding (GO:0001784),0.3477028673793674,0.9477228385337755,0.5533175355450237,0.9882328971836896,1.0,12/37,21.74%,IRS1;HCK;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;LCK;YES1;ABL2
prerank,Wnt-activated receptor activity (GO:0042813),-0.33244972870290224,-0.9472325515744702,0.5086505190311419,1.0,1.0,10/15,41.50%,RYK;TSPAN12;FZD7;FZD4;FZD6;FZD2;FZD5;FZD8;FZD1;FZD10
prerank,cadherin binding (GO:0045296),0.296093509146353,0.9446459209140247,0.657,0.9931711057572233,1.0,92/315,22.99%,STAT1;CHMP4B;ZC3HAV1;FMNL2;KDR;TRIM25;RARS1;CDH13;ACVR1;SH3GL1;PKN2;FLNB;LARP1;RSL1D1;HSP90AB1;GOLGA3;HNRNPK;CTNNB1;TNKS1BP1;SH3GLB1;IDH1;GAPVD1;MAPRE1;ARGLU1;CDH9;LASP1;RAB11B;NCK1;P2RX4;VAPB;PLCB3;BMPR2;HSPA8;FNBP1L;SNX9;LYPLA2;EIF4H;ATIC;HDLBP;FXYD5;CAPZB;TMOD3;PSEN1;PTPN11;TJP2;CTNNA3;KTN1;RACK1;RANBP1;CORO1B;SEPTIN9;UNC45A;CTNND2;DLG1;DBNL;BZW1;RPL23A;BAIAP2;BAIAP2L1;PPME1;KLC2;SNX1;IST1;TBC1D2;EPN2;LRRFIP1;CHMP5;AHSA1;MYH9;RPL24;CNN3;STK24;PTPRB;EIF5;ARHGAP18;RAB1A;PI4KA;TRPC4;EFHD2;DDX3X;CD46;RPL29;PSMB6;LDHA;USP8;RPL6;SNX2;CLIC1;ESYT2;TWF1;RAB10;EEF1G
prerank,endonuclease activity (GO:0004519),0.3353480482476268,0.9441152337264439,0.568445475638051,0.9914664738924016,1.0,8/49,12.53%,AGO2;APLF;NOB1;ZC3H12C;FEN1;ERCC4;ZC3H12A;ZRANB3
prerank,receptor tyrosine kinase binding (GO:0030971),0.32103000410126875,0.9435278151343713,0.5640138408304498,0.9898762153446192,1.0,9/56,12.99%,IRS1;CPNE3;ELMO2;DUSP3;PITPNM1;NCK1;SOCS5;STAP1;RACK1
prerank,telomeric DNA binding (GO:0042162),0.35295572713828854,0.9432107720373664,0.5480769230769231,0.987634495059241,1.0,10/32,18.77%,SMG7;HNRNPA2B1;SMG5;UPF2;UPF3A;TELO2;STN1;UPF1;HMBOX1;TERF2
prerank,kinesin binding (GO:0019894),0.3671014780371982,0.9416117532264648,0.5600505689001264,0.9887232472965766,1.0,8/27,16.52%,CLSTN1;MAPK8IP3;NEK6;ARHGEF10;PLEKHM2;ACTB;SPAG9;KLC2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3627896893354835,0.9413844661629985,0.5677018633540373,0.9861945715010693,1.0,9/32,21.94%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;MFSD12;SLC6A6
prerank,GABA-A receptor activity (GO:0004890),-0.30733507810569166,-0.9397359753601949,0.5361216730038023,1.0,1.0,9/18,36.75%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5;GABRR2;GABRE;GABRA4;GABRQ
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3010483116697137,0.9384987348541315,0.6139630390143738,0.9904296236699107,1.0,42/147,21.23%,DOCK8;RGP1;RINL;SPATA13;SBF1;RCC1L;ARHGEF7;HERC2;DENND1A;GAPVD1;RAPGEF6;RAPGEF2;CCDC88A;ABR;EIF2B2;VAV1;ANKRD27;ARHGEF11;RIN2;ARHGEF10;SOS1;FGD6;LAMTOR3;ARFGEF2;RIC1;RAPGEF1;AKAP13;IQSEC2;DENND10;MYCBP2;DENND6B;DENND4A;BCR;WDR41;PLCE1;EIF2B5;EIF2B3;DENND1B;LAMTOR4;DOCK10;DENND2D;DENND4B
prerank,retinoid binding (GO:0005501),-0.28661875577522133,-0.9335509670394249,0.5497835497835498,1.0,1.0,4/22,12.18%,PTGDS;RXRA;RARA;NR2F2
prerank,5'-nucleotidase activity (GO:0008253),0.4131625546535789,0.9324586020882207,0.5460992907801419,1.0,1.0,3/13,16.24%,NT5DC1;NT5C3A;NT5C3B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3654036688385805,0.9292348366341654,0.5803921568627451,1.0,1.0,5/24,11.76%,ITPKC;PPIP5K1;AK4;AK3;CMPK2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3613403427410999,0.929042544629799,0.5658056580565806,1.0,1.0,13/26,30.64%,ARPP19;PPP1R11;PPP1R1A;PPME1;MGAT5;SET;CABIN1;ENSA;BOD1;PPP1R14A;PPP1R2;PABIR1;LGALS3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.29316011470310116,0.9284160964826367,0.6773869346733669,1.0,1.0,46/254,18.67%,NR1H2;MEF2B;TFAP2C;ZBTB17;ESRRB;NFKB2;STAT3;ELK3;RUNX1;KLF15;MZF1;SOX9;ZNF76;TCF4;NFKB1;CREBRF;TFAP2B;UBP1;SRF;SMAD2;MEIS3;ATF6B;TFDP1;NFIB;ATF1;SCX;ELF4;TFDP2;MITF;KLF10;NR3C1;REL;PRDM4;E2F4;CASZ1;RREB1;MYB;SMARCD2;MEF2A;RBPJ;ELF1;ZNF445;FOSL2;HINFP;HOXA5;PRRX1
prerank,histone demethylase activity (GO:0032452),0.3549553204088566,0.9243827183672446,0.5840597758405978,1.0,1.0,7/27,16.02%,KDM4D;HR;KDM3B;RIOX2;FBXL19;KDM8;KDM7A
prerank,protein kinase C activity (GO:0004697),-0.329232229906572,-0.9234981123953784,0.570957095709571,1.0,1.0,4/14,12.73%,PRKCQ;PRKCZ;CCL3;PRKCI
prerank,protein heterodimerization activity (GO:0046982),0.2955024991597122,0.9216147087433396,0.6581892166836215,1.0,1.0,50/178,25.50%,SIM1;EXT1;USF2;ABCG1;TUBB2B;FBXO7;PAFAH1B3;CYBB;BHLHE40;ZHX3;TCOF1;RRAGC;TCF4;ITGA3;USF1;TFAP2B;NOLC1;BARD1;VAPB;UBA2;XBP1;GABBR2;MICU2;MEF2A;MIGA2;IRAK1;SNX1;MTTP;BAX;RALGAPB;LSM5;PAFAH1B1;BUD23;PSMF1;GADD45A;MCL1;TENM4;SNX2;RRAGA;ERBB3;BCL2L2;TAF7;CYBA;TENM1;YWHAE;EXT2;ATF6;GCA;EPAS1;KCNB1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4115626568409184,0.9213162449116414,0.5824964131994261,1.0,1.0,4/13,16.82%,SOX9;PRKAR2B;PRKAR2A;CSK
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2540668699996061,-0.9206530179250652,0.6143790849673203,1.0,1.0,8/34,15.36%,MYO10;FCHSD2;MYO1G;IQGAP1;RACGAP1;AKT1;MYO1B;ARAP3
prerank,TBP-class protein binding (GO:0017025),-0.28630904408171726,-0.9174467454600347,0.5889830508474576,1.0,1.0,6/21,17.44%,TAF12;ESR1;THRA;TAF1;PSMC1;AHR
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.34791686413571027,0.9173718386895655,0.5947867298578199,1.0,1.0,11/34,20.99%,METTL21A;NSD3;SETD3;EEF2KMT;MEN1;CAMKMT;EZH2;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.32684037470777505,-0.9155177031800801,0.5728476821192053,1.0,1.0,4/13,11.77%,GABRG3;GLRB;GABRA2;GLRA3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.28981023263410544,0.9144766517321034,0.6724313326551373,1.0,1.0,43/173,22.11%,TFAP2C;ZBTB17;NFX1;ZBTB2;ZFP37;BATF3;ELK3;NACC1;BHLHE40;MZF1;BCL6;NFKB1;BACH1;SNAI2;ETV6;AEBP1;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;SKIL;NR3C1;ZBTB21;MYPOP;ZBTB34;POU6F1;ERF;GTF2IRD1;PPARD;ZBTB4;LRRFIP1;ZBTB49;DACH1;ZKSCAN3;ZFP90;ZEB1;SCRT1;ZBTB20;E2F6;ZNF692;PRDM1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3945996158834447,0.913001501709883,0.5567715458276333,1.0,1.0,3/15,9.07%,AGPAT5;ABHD8;LPCAT2
prerank,methyltransferase activity (GO:0008168),0.32974758328470216,0.9127932117687853,0.6066897347174164,1.0,1.0,12/46,18.79%,COMTD1;BCDIN3D;MRM2;NTMT1;MEPCE;COQ3;DNMT1;COMT;GCSH;PRMT1;PRMT3;BUD23
prerank,enoyl-CoA hydratase activity (GO:0004300),0.43711013914644037,0.9116790539510036,0.5884101040118871,1.0,1.0,3/10,16.37%,AUH;ECHDC3;HADHA
prerank,insulin-like growth factor I binding (GO:0031994),-0.32937676875740496,-0.9111957878481175,0.5714285714285714,1.0,1.0,8/13,24.33%,ITGAV;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,aspartic-type peptidase activity (GO:0070001),0.4268032315889371,0.9107426325558876,0.5871559633027523,1.0,1.0,3/10,18.99%,PSEN1;NAPSA;DDI2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4343069942943872,0.9097208217114796,0.5829528158295282,1.0,1.0,1/10,0.80%,APOBEC1
prerank,voltage-gated chloride channel activity (GO:0005247),0.43650600427727715,0.9096987534716939,0.5720720720720721,1.0,1.0,2/10,5.86%,CLCN2;CLCN6
prerank,metallopeptidase activity (GO:0008237),0.2949084507126621,0.9045216370276764,0.6849894291754757,1.0,1.0,23/113,22.35%,ADAM33;LAP3;ADAMTS3;MMP14;ADAM8;ERAP1;NLN;ADAMTS19;PAPPA;ADAMTS2;PITRM1;ADAMTS12;ADAMTS6;NUDT16;SPRTN;METAP2;MPND;MIPEP;PSMD7;ADAMTS18;CHMP1A;MMP15;IDE
prerank,lysine N-methyltransferase activity (GO:0016278),0.37025675972294064,0.9039942174345137,0.5916775032509753,1.0,1.0,8/20,26.23%,METTL21A;SETD3;EEF2KMT;ATPSCKMT;SMYD2;SETD7;EEF1AKMT1;EHMT2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.2593418251044283,-0.9037244100723145,0.6287425149700598,1.0,1.0,18/32,40.49%,KCNC2;KCNH1;KCNQ5;KCNA2;KCNC3;KCNG2;KCNC1;KCNB2;KCNC4;KCNH2;KCNQ4;KCNQ1;KCNG1;KCNE3;KCNG4;KCNA6;KCNE4;KCNG3
prerank,myosin II binding (GO:0045159),0.4220096752626964,0.9031285413490499,0.591743119266055,1.0,1.0,3/10,16.42%,GSN;LLGL1;STXBP5L
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2643374169736476,-0.9022995837341955,0.611353711790393,1.0,1.0,9/24,33.75%,KCNJ10;KCNK6;KCNJ6;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4035626069485135,0.9016497903396804,0.6064880112834978,1.0,1.0,2/14,10.32%,BST2;TIMP2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.42552918978108356,0.9004846426687114,0.6035502958579881,1.0,1.0,2/10,8.86%,B4GALT1;B4GALT5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.41721096011277337,0.9003262949595389,0.6032210834553441,1.0,1.0,2/11,25.59%,SLC2A9;SLC17A5
prerank,MHC class II protein complex binding (GO:0023026),-0.3488129687591945,-0.8984617458460576,0.603030303030303,1.0,1.0,4/11,10.47%,CD81;ATP1B1;PKM;ANXA11
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.33438854224574366,0.8977801360321428,0.6178660049627791,1.0,1.0,5/33,6.75%,PNPT1;XRN2;CNOT7;XRN1;DCP2
prerank,CoA hydrolase activity (GO:0016289),0.38134516721678186,0.8968232508828748,0.6016597510373444,1.0,1.0,3/16,12.68%,ACOT9;ABCD1;ACOT13
prerank,GTPase inhibitor activity (GO:0005095),-0.3311003211662181,-0.8959765957012923,0.5960264900662252,1.0,1.0,6/13,20.61%,PDE6D;IQGAP1;ARL2;TNK2;GPS1;RTKN
prerank,deoxyribonuclease activity (GO:0004536),0.39887163472081544,0.8959764962131509,0.6225352112676056,1.0,1.0,3/14,12.53%,APLF;ERCC4;ZRANB3
prerank,cardiolipin binding (GO:1901612),0.42332146281790023,0.8949251733483249,0.6223241590214067,1.0,1.0,1/10,3.61%,PLEKHN1
prerank,phospholipase activator activity (GO:0016004),0.42443154860951665,0.8948463813988282,0.6144756277695717,1.0,1.0,5/10,23.51%,CCL5;STX4;FYN;LCK;PDPK1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3024594679537661,0.8944195519298931,0.6528384279475983,1.0,1.0,10/73,19.43%,RXFP2;GPR37L1;FPR3;S1PR2;GPR37;GALR1;INPP5K;HCRTR1;NLRP6;ADCYAP1R1
prerank,protein phosphatase activator activity (GO:0072542),0.4019406056080273,0.8941605798219795,0.6138032305433186,1.0,1.0,6/13,24.61%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3609576444580098,0.8933896034438003,0.6057818659658344,1.0,1.0,7/21,21.88%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,palmitoyltransferase activity (GO:0016409),0.34590941316291773,0.8900861476682567,0.624384236453202,1.0,1.0,12/28,27.26%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,lipase activity (GO:0016298),-0.23149103594078477,-0.8898877693762793,0.6834532374100719,1.0,1.0,14/43,21.63%,ABHD16A;LYPLA1;LIPH;SMPD3;PLBD1;PITPNM3;MGLL;ABHD12;LPL;FAAH;SEC23IP;PLA2G15;ABHD6;SMPD2
prerank,metalloaminopeptidase activity (GO:0070006),0.3792384563205133,0.8896253440398489,0.6096181046676096,1.0,1.0,6/16,24.07%,MMP14;ERAP1;NPEPPS;MMP15;TRHDE;RNPEP
prerank,MAP kinase kinase activity (GO:0004708),0.38831477325090247,0.8861997664489794,0.6256983240223464,1.0,1.0,4/15,11.83%,PAK3;MAP2K3;MAPK14;MAP2K2
prerank,RNA stem-loop binding (GO:0035613),0.4045079680509589,0.885847722729812,0.6222547584187409,1.0,1.0,5/12,20.49%,DHX9;ZC3H12A;RC3H2;CSDE1;DDX3X
prerank,ionotropic glutamate receptor activity (GO:0004970),0.3737170844472525,0.883710872130533,0.6231292517006802,1.0,1.0,3/17,6.57%,GRIN2D;GRIK3;GRIA2
prerank,ATPase regulator activity (GO:0060590),0.3219964423471165,0.8825371801941625,0.6393831553973903,1.0,1.0,10/38,20.84%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6;BAG1;AHSA1;FNIP2;TSC1;HSPBP1
prerank,anion channel activity (GO:0005253),-0.21528700794096617,-0.8816757580195237,0.7473684210526316,1.0,1.0,17/61,22.21%,GABRG3;VDAC1;CLCN5;GABRB1;GLRB;GABRA2;GPR89B;GPR89A;GLRA3;SLC1A4;GABRB3;SLC26A8;GABRA5;LRRC8A;CLCN4;ANO6;FXYD1
prerank,hydro-lyase activity (GO:0016836),0.32373860440510616,0.8772063804175574,0.6572104018912529,1.0,1.0,9/41,16.37%,CA4;AUH;ECHDC3;HACD3;CDYL;CA2;UROS;TGDS;HADHA
prerank,acetylcholine receptor activity (GO:0015464),-0.2741977765256092,-0.875116437757982,0.6507936507936508,1.0,1.0,4/22,21.25%,CHRNA7;CHRFAM7A;CHRM2;CHRNA4
prerank,thioesterase binding (GO:0031996),0.40186836391641473,0.8750897567945075,0.6321167883211679,1.0,1.0,4/11,14.01%,TRAF4;TRAF3;TRAF5;RAC1
prerank,gap junction channel activity (GO:0005243),0.3556438683231,0.8750859276371022,0.6387096774193548,1.0,1.0,2/22,11.22%,PANX2;PANX1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.33262403076402597,0.8742887640845212,0.6560587515299877,1.0,1.0,9/31,17.79%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,Notch binding (GO:0005112),0.35047997930910696,0.8741198019119923,0.6474442988204456,1.0,1.0,8/22,23.74%,DLK2;MEGF10;SNW1;NOTCH4;DNER;AAK1;CUL3;NCOR2
prerank,exonuclease activity (GO:0004527),0.31026261471262645,0.8728586109469995,0.6604651162790698,1.0,1.0,10/46,14.16%,XRN2;APLF;ENPP3;AEN;CNOT7;FEN1;ZC3H12A;ENPP1;EXOSC9;REXO1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3069013664123582,0.871262613988706,0.681766704416761,1.0,1.0,13/53,22.19%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;CTNS;SLC25A12;SLC36A4;SFXN1;SLC25A15;SLC7A7;SLC1A3
prerank,phosphatase binding (GO:0019902),0.2883029910066796,0.8704050657292044,0.7174139728884255,1.0,1.0,21/105,14.75%,FCRL6;STAT3;ANAPC5;IKBKE;CTNNB1;ANK1;NFATC2;MAGI2;CTSC;PPP6R3;SMAD2;ANAPC4;VRK3;MET;MAPK14;TRAF3;CDC27;RACK1;BAD;DLG1;DZIP3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3944456827624845,0.8671891367535042,0.6336206896551724,1.0,1.0,4/12,16.02%,KDM4D;HR;KDM3B;KDM7A
prerank,GDP binding (GO:0019003),0.2967295611735319,0.8669962600744985,0.6856516976998904,1.0,1.0,9/63,11.03%,RAB8B;RAB21;RHEBL1;RAB12;RRAGC;RAB22A;RAB11B;RAB5C;RAB14
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.34521373965164825,0.866522286102796,0.6528497409326425,1.0,1.0,7/23,21.88%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,cell adhesion mediator activity (GO:0098631),0.3466287239299323,0.8654359669178627,0.6507115135834411,1.0,1.0,7/24,20.02%,CD47;PLXNB3;NPTN;DSCAM;DSCAML1;JAM3;SIRPA
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.30638213203649944,-0.8652362731819215,0.6280701754385964,1.0,1.0,6/15,19.61%,NDST3;HS6ST3;HS2ST1;HS3ST2;HS3ST3A1;HS3ST5
prerank,ferrous iron binding (GO:0008198),0.35453538350718367,0.8652148802259969,0.6666666666666666,1.0,1.0,5/21,14.76%,FXN;EGLN2;ALKBH1;ALKBH2;TET2
prerank,peptidase inhibitor activity (GO:0030414),0.3225198306188018,0.8648084072429432,0.6442080378250591,1.0,1.0,5/33,11.79%,SLPI;UCHL5;CST7;TIMP2;USP14
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2622619828844553,-0.8636611868337991,0.6701030927835051,1.0,1.0,9/27,23.78%,SLC9A9;SLC8A3;SLC4A8;SLC3A2;PKD2L1;SLC9A8;CNNM4;SLC8A2;SLC9B2
prerank,cation:chloride symporter activity (GO:0015377),-0.3430646159406986,-0.862898889698436,0.632258064516129,1.0,1.0,2/10,2.40%,SLC12A6;SLC12A2
prerank,NADP binding (GO:0050661),0.32939430460412233,0.8619525855132918,0.6587112171837709,1.0,1.0,4/32,8.34%,DHFR;GRHPR;PGD;HSD11B1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3362844009351283,0.860744996135676,0.6713554987212276,1.0,1.0,8/26,24.65%,SLC27A1;SLC16A13;SLC16A14;SLC16A6;ABCG2;SLC5A6;SLC6A6;SLC16A4
prerank,poly-purine tract binding (GO:0070717),0.3363976163318988,0.8585916556703117,0.67875,1.0,1.0,13/27,29.44%,PNPT1;RBMS2;HNRNPDL;ATXN1;DAZAP1;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC4;PABPC1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.36387251162895273,0.8585906873359962,0.6564245810055865,1.0,1.0,3/16,14.86%,SLC25A22;SLC25A10;SLC25A12
prerank,sodium channel activity (GO:0005272),0.3173700053304361,0.8580256386453919,0.6750599520383693,1.0,1.0,11/37,27.01%,GRIK3;ASIC4;SCN2A;SCN1B;SCN8A;HCN2;GRIK4;GRIK2;GRIK5;SHROOM2;SCN4B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.31789335431557114,-0.8571484620809852,0.6511627906976745,1.0,1.0,4/13,11.14%,DNASE1L1;ZGRF1;SLX4;DNA2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.35692906717691675,0.8543352611759277,0.6573426573426573,1.0,1.0,4/17,11.76%,NOL9;AK4;AK3;CMPK2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3658071739920249,0.8538138389278653,0.6718092566619915,1.0,1.0,3/17,12.68%,ACOT9;ABCD1;ACOT13
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.28766902575089004,0.8511317187704466,0.7242128121606949,1.0,1.0,16/72,19.75%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;LDLRAP1;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;TULP3;PHLDA3;MARK1;OSBPL2;PLA2G4E
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3012945442348511,-0.8493055973381498,0.6677018633540373,1.0,1.0,5/14,16.37%,MTMR4;MTMR1;MTMR9;MTMR10;MTM1
prerank,retinoid X receptor binding (GO:0046965),0.39109323524256134,0.8492839146755166,0.6632200886262924,1.0,1.0,1/11,2.13%,RARG
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.33300475238695937,0.8478220707176102,0.691025641025641,1.0,1.0,10/25,26.84%,ADAP2;KIF16B;PLEKHA1;PLEKHA4;PHLDA3;PLA2G4E;ZFYVE1;COMMD1;GAB2;PLEKHA2
prerank,dynactin binding (GO:0034452),-0.3253798531331381,-0.8474480360219626,0.6688311688311688,1.0,1.0,3/12,8.56%,BICDL1;HTT;GSK3B
prerank,solute:anion antiporter activity (GO:0140323),0.3679222515277143,0.846746945912263,0.6537356321839081,1.0,1.0,3/14,16.48%,SLC26A1;SLC26A2;SLC4A2
prerank,death receptor binding (GO:0005123),0.361136410565714,0.8457240021180258,0.6554149085794655,1.0,1.0,2/15,3.93%,BDNF;FEM1B
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3195513389145156,-0.8454445616276677,0.6697530864197531,1.0,1.0,4/12,9.10%,PIK3C2A;IPMK;PIK3C3;PIK3CG
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3383191992461616,0.8452485836282012,0.6692307692307692,1.0,1.0,3/24,5.19%,GOLGA7;ZDHHC21;ZDHHC20
prerank,translation elongation factor activity (GO:0003746),-0.30345901530588126,-0.8430545192368208,0.6754098360655738,1.0,1.0,6/14,24.66%,EEF1A1;EEF1B2;TSFM;EIF5A2;GTPBP1;EEF1A2
prerank,wide pore channel activity (GO:0022829),0.3391577952525256,0.8422974125098954,0.6906290115532734,1.0,1.0,2/23,11.22%,PANX2;PANX1
prerank,sialyltransferase activity (GO:0008373),0.34943737691643567,0.841689392524183,0.6822558459422283,1.0,1.0,4/20,9.76%,ST6GALNAC4;ST6GAL1;ST6GALNAC6;ST3GAL1
prerank,endoribonuclease activity (GO:0004521),0.31619687366268434,0.8408548891356633,0.6869565217391305,1.0,1.0,7/32,19.70%,AGO2;NOB1;ZC3H12C;ZC3H12A;DICER1;ENDOV;ERN1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.38232972628353645,0.8396200562331059,0.6792738275340393,1.0,1.0,4/12,20.21%,ACVR1;BMPR2;BMPR1A;ACVRL1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3496350431696292,0.8392846584334878,0.6803840877914952,1.0,1.0,5/18,20.21%,ACVR1;BMPR2;BMPR1A;ACVR2A;ACVRL1
prerank,metalloendopeptidase activity (GO:0004222),0.2807244223248859,0.8380454310015716,0.7519042437431991,1.0,1.0,11/76,17.56%,ADAM33;ADAMTS3;MMP14;NLN;ADAMTS19;ADAMTS2;PITRM1;ADAMTS12;ADAMTS6;SPRTN;MIPEP
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.2823328726441547,-0.8371769902029296,0.7245762711864406,1.0,1.0,6/18,21.40%,PDLIM5;PDLIM1;S100A11;CDC42EP1;ANXA1;STXBP6
prerank,calcium channel regulator activity (GO:0005246),0.309012320065523,0.8345963612677808,0.6838323353293413,1.0,1.0,4/37,6.05%,SGK3;ITPR1;SLC30A1;INAFM1
prerank,active ion transmembrane transporter activity (GO:0022853),0.30900498672794485,0.8344350064748879,0.7063679245283019,1.0,1.0,3/37,6.37%,UQCRQ;SLCO1C1;SLCO1B1
prerank,cytokine receptor activity (GO:0004896),0.27963404234454636,0.8337949301396851,0.7547770700636943,1.0,1.0,17/83,21.47%,CRLF1;IL15RA;IL21R;IL17RC;IL10RA;IL12RB2;LEPR;GFRA2;IL10RB;IFNAR2;IL1RAP;CSF2RA;IFNGR2;IFNGR1;EBI3;F3;IL4R
prerank,transcription coactivator binding (GO:0001223),0.3392382713378686,0.8324748616230494,0.6706827309236948,1.0,1.0,6/20,17.71%,ZBTB17;TEAD2;CCNT2;RORA;PPARD;ZBTB49
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3158308322646492,0.8321089411402303,0.7107540173053152,1.0,1.0,11/29,28.09%,SPRY2;CDKN2D;PRKAR2B;CIB1;PRKAR2A;SPRED1;YWHAG;KAT2B;CDKN2A;PKIB;PRKAR1A
prerank,platelet-derived growth factor binding (GO:0048407),-0.314849842255456,-0.8313513437332137,0.653179190751445,1.0,1.0,6/11,31.85%,COL1A2;COL4A1;PDGFRA;COL6A1;PDGFRB;COL5A1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.31088092377476645,0.8311660152461502,0.715311004784689,1.0,1.0,9/34,17.79%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.32806059919670244,-0.8305719121301492,0.6950146627565983,1.0,1.0,2/10,8.96%,GABRG3;GABRA2
prerank,general transcription initiation factor binding (GO:0140296),-0.24480382498579972,-0.8302262134097382,0.7297297297297297,1.0,1.0,7/25,13.02%,AR;TAF12;ESR1;THRA;TBP;TAF1;PSMC1
prerank,phosphatase activity (GO:0016791),0.2818967640698892,0.8283856895911542,0.7537960954446855,1.0,1.0,27/73,26.68%,DUSP3;PDXP;SBF1;LPIN2;DUSP26;DUSP28;EPHX2;DUSP10;DUSP16;DUSP11;INPP5K;NUDT16;OCRL;DUSP8;MINPP1;SACM1L;LHPP;PGAM5;PLPP2;MDP1;PLPPR2;FRA10AC1;PLPPR1;PLPP6;PLPP1;NT5C;NOCT
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2419760214753925,-0.8262837018427837,0.7527472527472527,1.0,1.0,10/28,21.85%,MAP2K6;SGK1;MAP3K9;RPS6KA2;TNK2;AKT1;MAP2K5;MAPKAPK5;PRKCG;RPS6KA1
prerank,solute:sodium symporter activity (GO:0015370),-0.23695097370655577,-0.8252877336005209,0.7438423645320197,1.0,1.0,10/27,41.46%,SLC20A1;SLC4A8;SLC28A2;SLC4A9;SLC4A7;SLC4A10;SLC13A5;SLC5A3;SLC28A1;SLC4A5
prerank,microtubule binding (GO:0008017),0.25937142606814567,0.823484799741244,0.857286432160804,1.0,1.0,52/222,19.39%,SBDS;KIF26A;KIF3C;KIF7;REEP2;POLB;KIF2C;KIF3B;HOOK2;SAXO2;MAPRE1;CETN3;CEP57L1;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;TOGARAM2;SPEF1;CCDC88B;DNM2;CCDC181;SUN2;UXT;MAP1LC3B;TRPV4;FGF13;CLIP2;WHAMM;REEP3;CCDC61;HOOK3;CEP295;MAP4;KIF2A;CCDC66;GAS2L3;RAB11A;CLIP4;RMDN1;CAMSAP2;PAFAH1B1;KIF19;SVBP;FNTA;NUMA1;MAP1B;CCDC69
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2939725937818951,0.8226431996568955,0.7525891829689298,1.0,1.0,6/47,9.40%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3169506958422724,0.8201018117146625,0.7036569987389659,1.0,1.0,8/29,19.38%,HEXD;NEU1;GANC;HPSE;HPSE2;ACER3;GBA2;ABHD10
prerank,exopeptidase activity (GO:0008238),0.288008099630089,0.8181823479555144,0.7456846950517837,1.0,1.0,16/50,26.10%,LAP3;DPEP2;ERAP1;CTSH;DPP3;NPEPPS;KDM8;NUDT16;METAP2;FOLH1;CNDP2;TRHDE;RNPEP;DPP10;DPP6;CPM
prerank,motor activity (GO:0003774),0.2816103030299022,0.8178549536437025,0.7647714604236343,1.0,1.0,14/60,20.55%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B;MYO6;KIF2A;APPBP2;DYNC2H1;MYH9;KIF19;PIN1;STARD9
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38078919915473686,0.8171761924099971,0.675187969924812,1.0,1.0,4/11,22.46%,ITPR1;RPH3A;TRPC4;TRPC1
prerank,protein kinase C binding (GO:0005080),0.29456720466863606,0.8158362174256253,0.7449822904368358,1.0,1.0,7/43,13.32%,IRS1;NELL2;CCDC88A;DACT1;TRPV4;RACK1;NELL1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3582037117574351,0.8157862546937357,0.7079276773296245,1.0,1.0,6/13,20.62%,TRMT1;WDR4;TRMT10C;THUMPD3;METTL1;TARBP1
prerank,diacylglycerol kinase activity (GO:0004143),-0.31351122006708787,-0.8149625876953346,0.703030303030303,1.0,1.0,4/11,12.24%,DGKH;DGKZ;DGKD;DGKE
prerank,pseudouridine synthase activity (GO:0009982),0.363316614889005,0.8125406108297288,0.6989720998531571,1.0,1.0,4/13,21.54%,PUS7L;PUS7;RPUSD1;PUS10
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.37044701012465825,0.8122699275052006,0.6768558951965066,1.0,1.0,7/11,27.79%,AMFR;RBX1;UBE4B;UBE2K;STUB1;PRPF19;ANAPC11
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3188743573134079,0.8121268930512826,0.7380352644836272,1.0,1.0,5/27,10.15%,AUP1;SIAH1;DCUN1D4;RNF19B;ARIH1
prerank,voltage-gated cation channel activity (GO:0022843),0.26996926940642535,0.8118514497725512,0.8134171907756813,1.0,1.0,8/97,9.74%,CATSPER4;CACNA2D4;GRIN2D;TMC1;KCNH8;KCNS3;CACNA1A;KCNA4
prerank,Tat protein binding (GO:0030957),0.3832127456738839,0.8113398961988405,0.6982507288629738,1.0,1.0,3/10,13.99%,MDFIC;NPM1;ACTB
prerank,pre-mRNA binding (GO:0036002),0.3128001666163573,0.8111829735174095,0.7167919799498746,1.0,1.0,6/28,12.75%,DDX5;TARBP2;RNPC3;HNRNPL;HNRNPA1;RBM41
prerank,fibroblast growth factor binding (GO:0017134),0.3301194586309679,0.8092282199291678,0.7186700767263428,1.0,1.0,7/21,26.19%,FGFR2;FGFR3;FIBP;FGFRL1;S100A13;GLG1;CEP57
prerank,tropomyosin binding (GO:0005523),-0.2814945995513002,-0.8091814902476842,0.7346938775510204,1.0,1.0,12/16,50.24%,CALD1;NEBL;TMOD1;TNNT3;SMTNL2;LMOD3;TMOD2;PYCARD;LMOD1;TNNT2;TMOD4;TNNT1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.359708763752436,0.8052587468053816,0.6843575418994413,1.0,1.0,3/13,13.05%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.328723678505329,-0.8026417823337506,0.7319277108433735,1.0,1.0,2/10,11.50%,DPYSL3;CRMP1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.25492842142810357,0.8024428550343623,0.8675429726996967,1.0,1.0,22/188,10.98%,PITX2;PER2;STAT3;ARID5B;RBBP5;RUNX1;KLF15;DHX36;MZF1;TCF7L2;NFKB1;DHX9;ATF6B;CDK5RAP2;NONO;TAF2;HMGB1;HNRNPL;MEN1;PROX1;FOXK1;CTCF
prerank,mitogen-activated protein kinase binding (GO:0051019),0.30595770184895954,0.7971943775680128,0.7422062350119905,1.0,1.0,8/29,18.47%,NBR1;MAPK14;TNIP1;GCH1;DUSP10;DUSP16;PRMT1;DUSP8
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2997198037439503,0.7957030359512121,0.7333333333333333,1.0,1.0,9/32,18.43%,EGLN2;ALKBH1;RIOX2;ALKBH2;KDM8;TET2;KDM7A;JMJD4;P4HTM
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.3050740540643813,0.795521371533568,0.7406015037593985,1.0,1.0,4/27,11.42%,SLC26A1;ANKH;SLC25A10;SLC26A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.344944872039423,0.7942084847469784,0.7083333333333334,1.0,1.0,1/15,4.59%,PLA2G12A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.28780701733474945,0.7938241278006457,0.7579318448883666,1.0,1.0,5/40,9.14%,COMTD1;MEPCE;SETD3;DNMT3A;DNMT1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3302656277977273,0.79201562317743,0.7334273624823695,1.0,1.0,3/18,8.55%,USP15;SMAD2;BAMBI
prerank,histone methyltransferase activity (GO:0042054),0.3012524758827462,0.7897499208201559,0.7822966507177034,1.0,1.0,9/32,20.99%,PRMT2;NTMT1;NSD3;MEN1;EZH2;PRMT1;SMYD1;SMYD2;SETD7
prerank,myosin V binding (GO:0031489),0.3438055477257678,0.7897471903134273,0.7521008403361344,1.0,1.0,6/15,26.53%,RAB11B;RAB14;RAB11A;RAB10;RAB3A;RAB3D
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2964466398898619,-0.7830960292874488,0.7360248447204969,1.0,1.0,6/12,33.74%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3461013450289887,0.7827735444960758,0.7475035663338089,1.0,1.0,1/14,0.81%,SLC25A22
prerank,anion:anion antiporter activity (GO:0015301),0.3265407005431101,0.7806060684796472,0.7434842249657064,1.0,1.0,4/17,16.48%,SLC26A1;SLC19A1;SLC26A2;SLC4A2
prerank,beta-tubulin binding (GO:0048487),0.2955303076657606,0.78047736021212,0.7667525773195877,1.0,1.0,7/31,15.51%,DLEC1;VAPB;TTLL7;UXT;TRPV4;FGF13;TBCD
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.29637601428954885,0.7801076809377964,0.7746305418719212,1.0,1.0,5/31,14.13%,TMEM38A;SLC12A5;SLC12A8;KCNK3;TMEM38B
prerank,small GTPase binding (GO:0031267),0.24571062398682306,0.7777071713577707,0.8830111902339777,1.0,1.0,50/169,24.30%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;CYFIP1;GGA3;KIF3B;UNC13D;RAPGEF6;RAP1GAP;SIKE1;SPHK2;CIB1;ANKFY1;ANKRD27;SORL1;SRGAP2;FGD6;RIC1;AKAP13;WHAMM;RANBP1;DENND10;MYCBP2;LZTR1;OCRL;PEX5;PLCE1;RANBP9;NCKAP1;SGSM1;SGSM3;STRN3;GCC1;OPTN;RHOH;USP33;IQGAP2;BRK1;CCDC186;RAB29;ARHGAP1;RAF1;FLNA;RIN3;BICD2;EXOC2
prerank,potassium ion leak channel activity (GO:0022841),-0.2768676336578252,-0.7774791535646883,0.7566539923954373,1.0,1.0,7/15,36.17%,KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.2742551132939718,-0.7770095934878304,0.8028169014084507,1.0,1.0,2/16,1.24%,MACROD2;CD38
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.32949283970627113,0.7766498901594348,0.7466307277628033,1.0,1.0,2/15,11.42%,SLC26A1;SLC26A2
prerank,NF-kappaB binding (GO:0051059),0.3061224770409412,0.7766155226254908,0.7736093143596378,1.0,1.0,6/24,18.30%,TAF4B;COMMD7;NPM1;RNF25;ANXA4;HDAC1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.37295036105192675,0.7766070163719739,0.7402985074626866,1.0,1.0,1/10,3.69%,CYBB
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.31300451703230286,0.7760150663858745,0.7735602094240838,1.0,1.0,3/23,9.34%,PLCB4;CCL5;PLCB3
prerank,tau protein binding (GO:0048156),0.2835021297923522,0.7756702540565065,0.7845238095238095,1.0,1.0,16/40,27.30%,CLU;HSP90AB1;SMAD2;APOE;ACTB;FYN;HSP90AA1;TAOK2;MARK1;BRSK1;PIN1;STUB1;HDAC6;DCTN1;EP300;CDK5
prerank,cell-cell adhesion mediator activity (GO:0098632),0.28380773558302314,0.7746570662783799,0.7888493475682088,1.0,1.0,14/42,25.43%,CD47;PLXNB3;TMOD3;NPTN;DSCAM;BAIAP2;DSCAML1;BAIAP2L1;JAM3;CNN3;SIRPA;RAB10;ANXA2;CNTN2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.31138846486710636,-0.7703069924731911,0.7570093457943925,1.0,1.0,4/11,9.11%,STK38;TRAF6;MAP3K11;DAB2IP
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.365884909172587,0.7701760037498206,0.7563150074294205,1.0,1.0,1/10,4.00%,CD47
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.30754382878787007,0.7696481960218853,0.771353482260184,1.0,1.0,6/23,19.75%,KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;GBF1;PLA2G4E
prerank,tubulin binding (GO:0015631),0.2408589707268633,0.76754506618009,0.9359359359359359,1.0,1.0,98/295,27.47%,GPAA1;SBDS;KIF26A;B9D2;KIF3C;KIF7;REEP2;POLB;KIF2C;ARHGEF7;KIF3B;HOOK2;SAXO2;EFHC2;DLEC1;CETN3;CEP57L1;STMN4;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;TOGARAM2;SPEF1;TPPP3;GIT1;STMN3;CCDC88B;DNM2;CCDC181;SUN2;TTLL7;UXT;MAP1LC3B;TRPV4;FGF13;CLIP2;WHAMM;REEP3;CCDC61;HOOK3;FYN;CEP295;MAP4;KIF2A;CCDC66;GAS2L3;TBCD;RAB11A;DNAL1;STMN2;RMDN1;PAFAH1B1;KIF19;SVBP;FNTA;BRSK1;NUMA1;MAP1B;CCDC69;DDX3X;STARD9;TRAPPC14;CRIPT;DIXDC1;MAP6D1;RAB11FIP5;MAPRE3;MDM1;KIF21A;OPA1;DNM3;HDAC6;ARL4C;BBS4;DCTN1;HAUS6;MAPRE2;RAD51D;CHP1;EML5;ABRAXAS2;CEP57;MAST2;CDK5R1;TUBGCP5;KIF13B;KIF1A;DNM1;SNPH;LRPPRC;CDK5;ATF5;MAP1S
prerank,G protein-coupled receptor activity (GO:0004930),-0.1467593768572534,-0.7671220016565486,1.0,1.0,1.0,107/239,41.61%,GRM3;GPR183;CNR2;CALCRL;LPAR1;PTAFR;ADGRL1;OPRM1;C5AR2;GPR45;CX3CR1;GPR34;HRH1;ADGRL3;GPR149;P2RY14;XPR1;GPR173;ADGRA1;ADGRB3;GRM8;CMKLR1;GLP2R;TAPT1;ADGRG3;HCRTR2;S1PR1;NTSR2;F2R;QRFPR;PDGFRL;S1PR5;GPR135;ADGRB2;NPR3;ADRA2A;PAX8;P2RY1;DRD2;OPRL1;OPRK1;GPR85;OPN3;GPR75;LPAR6;PDGFRB;GPR26;CRHR1;GPR61;GPR101;TSHR;PTH2R;GPR18;ADRB2;GRPR;F2RL2;ADGRB1;NPR1;OPRD1;MRGPRE;NPFFR2;GPR161;GPR27;LANCL1;GPR65;GPR88;MC5R;HCAR2;SSTR2;FFAR1;NMUR2;BDKRB2;NPY;GPR171;ADGRE5;ADGRG5;S1PR3;DRD3;GPR174;LTB4R;LPAR4;CXCR5;LPAR2;KISS1R;FFAR4;VIPR2;APLNR;CXCR6;PTH1R;CYSLTR1;NTSR1;NMBR;GLP1R;GPR17;RRH;LGR5;ADGRL2;SCTR;S1PR4;ADORA2A;AVPR2;ADGRG6;MC4R;GPR52;LPAR3;ADGRG7;P2RY10
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3326663958033756,0.7644041912468563,0.7713498622589532,1.0,1.0,1/15,0.81%,SLC25A22
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.22292539995436836,-0.7642081840886342,0.8551401869158879,1.0,1.0,6/26,16.52%,CHSY1;CSGALNACT1;B3GNT2;B3GALT5;B3GALT2;B4GALNT1
prerank,snoRNA binding (GO:0030515),-0.21858700563701794,-0.7628203837635983,0.875,1.0,1.0,11/30,22.68%,XRCC5;NOP56;NUDT7;NOP58;TBL3;IMP3;NOP14;NUDT16L1;NUDT1;NUFIP1;BYSL
prerank,kinase inhibitor activity (GO:0019210),0.28644291938964794,0.762385043169069,0.7955607476635514,1.0,1.0,6/33,13.93%,TAOK3;SOCS1;GMFB;NCK1;NPM1;DUS2
prerank,ribosome binding (GO:0043022),0.2709384461111608,0.761963573216038,0.8231917336394948,1.0,1.0,10/46,18.34%,SBDS;YTHDF1;MTIF3;ZC3H12A;EIF6;RACK1;EIF2S1;ETF1;NOMO1;CPEB2
prerank,GABA receptor activity (GO:0016917),-0.23563116939306225,-0.7611283444269887,0.8367346938775511,1.0,1.0,3/21,8.96%,GABRG3;GABRB1;GABRA2
prerank,peptide hormone receptor binding (GO:0051428),-0.2855749524998551,-0.7610130116497312,0.7948717948717948,1.0,1.0,5/11,40.30%,ADCYAP1;PTHLH;GNRH1;PSMC5;VIP
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.2975614537934902,-0.7609418715208666,0.7840236686390533,1.0,1.0,6/11,25.56%,SAMD8;AASDHPPT;SGMS2;SGMS1;PIGO;PTDSS2
prerank,pyridoxal phosphate binding (GO:0030170),0.30604533573289805,0.7606080337284953,0.7786666666666666,1.0,1.0,1/20,0.65%,AGXT
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.26659738864235594,-0.7604063632522076,0.7777777777777778,1.0,1.0,9/14,46.81%,KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,potassium ion antiporter activity (GO:0022821),-0.2716491696976906,-0.7600807985679799,0.8066914498141264,1.0,1.0,1/15,1.06%,SLC9A9
prerank,alpha-tubulin binding (GO:0043014),0.2852509999274161,0.7598271667305813,0.7997465145754119,1.0,1.0,12/31,26.45%,EFHC2;DLEC1;TTLL7;TRPV4;FYN;DNAL1;FNTA;TRAPPC14;HDAC6;ARL4C;BBS4;CDK5R1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2506426375896922,0.7590587153089621,0.8625393494228751,1.0,1.0,30/100,25.06%,SAP30L;PLEKHN1;GAP43;OSBPL8;DENND1A;RUBCNL;ADAP2;ZFYVE26;KIF16B;ANKFY1;RUBCN;PLEKHA4;PLEKHA3;RPH3A;OSBP;SNX24;SH3PXD2B;PHLDA3;GBF1;GOLPH3L;ARAP1;DENND1B;PLA2G4E;IQGAP2;CERT1;ZFYVE1;ARAP2;SNX12;COMMD1;GAB2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2811617892579963,0.7587752446793229,0.8085365853658537,1.0,1.0,9/34,19.72%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2811617892579963,0.7587752446793229,0.8085365853658537,1.0,1.0,9/34,19.72%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.25026136610336114,0.7570777290275363,0.8780487804878049,1.0,1.0,19/91,19.75%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;LDLRAP1;KIF16B;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;SH3PXD2B;TULP3;PHLDA3;GBF1;MARK1;OSBPL2;PLA2G4E
prerank,epidermal growth factor receptor binding (GO:0005154),0.2940820627082191,0.7568097268155446,0.8052631578947368,1.0,1.0,8/25,26.97%,TGFA;CCDC88A;ARF4;SNX1;SNX2;LINGO1;SHC1;FER
prerank,growth factor receptor binding (GO:0070851),0.2496577512179184,0.7556410485894822,0.8833693304535637,1.0,1.0,18/95,22.16%,TGFA;ERAP1;CCDC88A;TIMM50;VEGFD;FGF9;PSEN1;FYN;IL1RAP;JAK2;PIBF1;ARF4;SNX1;CD300LF;ERN1;TRIP6;FGF2;SNX2
prerank,acylglycerol lipase activity (GO:0047372),-0.29152481842016,-0.7552540242936515,0.7909967845659164,1.0,1.0,6/11,25.54%,ABHD16A;MGLL;ABHD12;FAAH;ABHD6;ABHD15
prerank,BMP binding (GO:0036122),0.3500448110321961,0.7527317674976347,0.7808022922636103,1.0,1.0,1/11,9.69%,BMPR2
prerank,GTPase binding (GO:0051020),0.2375837540925972,0.752529607974224,0.9257375381485249,1.0,1.0,55/194,24.30%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;RRAGC;CYFIP1;GGA3;KIF3B;UNC13D;RAPGEF6;RAP1GAP;SIKE1;SPHK2;FNBP1L;CIB1;ANKFY1;ANKRD27;SORL1;SRGAP2;IARS1;FGD6;RIC1;AKAP13;WHAMM;RANBP1;HSP90AA1;DENND10;MYCBP2;LZTR1;OCRL;PEX5;PLCE1;BECN1;RANBP9;NCKAP1;SGSM1;SGSM3;STRN3;GCC1;OPTN;RHOH;USP33;IQGAP2;BRK1;CCDC186;RAB29;ARHGAP1;RAF1;FLNA;RIN3;BICD2;EXOC2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2815443545622913,-0.7499209348024481,0.7901639344262295,1.0,1.0,6/12,26.04%,CRYZL1;AIFM2;CBR1;NQO2;DCXR;CRYZ
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3544728415764252,0.7498238492536767,0.7766423357664234,1.0,1.0,2/11,15.95%,NAA50;NAA25
prerank,nuclear export signal receptor activity (GO:0005049),0.3445221333250512,0.7479682225466882,0.7855029585798816,1.0,1.0,2/11,16.77%,CSE1L;RANBP17
prerank,phosphatidylinositol kinase activity (GO:0052742),0.33232162156108735,0.7464650583325253,0.7851002865329513,1.0,1.0,3/15,13.11%,PIK3CD;PI4KB;PIK3CB
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3569833430282693,0.7441487932362841,0.7653543307086614,1.0,1.0,2/10,13.11%,PIK3CD;PIK3CB
prerank,mechanosensitive ion channel activity (GO:0008381),0.3405147332841701,0.7435379539382185,0.7885196374622356,1.0,1.0,1/12,2.43%,TMC1
prerank,ankyrin binding (GO:0030506),-0.24781159144757076,-0.7431514654473671,0.8308270676691729,1.0,1.0,4/19,17.03%,SPTB;SPTBN4;PLEC;NRCAM
prerank,Hsp70 protein binding (GO:0030544),0.27842575921819307,0.7419975227096199,0.8361650485436893,1.0,1.0,3/31,6.61%,NOD2;METTL21A;GPR37
prerank,peptide N-acetyltransferase activity (GO:0034212),0.35849563586639643,0.7413803035046883,0.7931547619047619,1.0,1.0,2/10,15.95%,NAA50;NAA25
prerank,potassium channel activity (GO:0005267),0.246083696794956,0.7396694777866067,0.8859556494192186,1.0,1.0,8/89,11.84%,KCNMB3;GRIK3;TMEM38A;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,cation transmembrane transporter activity (GO:0008324),0.2632357439048344,0.7393027394917816,0.8523255813953489,1.0,1.0,10/48,21.94%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;SLC25A15;MFSD12;SLC6A6
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.25699451808468526,-0.7381657291848512,0.8098591549295775,1.0,1.0,3/16,8.95%,PTPRK;PTPRA;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.25699451808468526,-0.7381657291848512,0.8098591549295775,1.0,1.0,3/16,8.95%,PTPRK;PTPRA;PTPRG
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3179530243612703,0.7378472656693925,0.7840755735492577,1.0,1.0,3/15,13.05%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,lipase activator activity (GO:0060229),0.3508073029804966,0.7374268628648696,0.7817109144542773,1.0,1.0,4/10,23.51%,CCL5;FYN;LCK;PDPK1
prerank,phospholipase binding (GO:0043274),-0.26450572731637123,-0.7305178386757274,0.8361204013377926,1.0,1.0,7/13,29.63%,SYK;SRC;WAS;BTK;ARHGAP6;PRKN;DGKQ
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.29312873650065374,0.7304404374267776,0.8277202072538861,1.0,1.0,7/24,22.55%,OSBPL8;RUBCNL;PLEKHA3;OSBP;GOLPH3L;PLA2G4E;CERT1
prerank,snRNA binding (GO:0017069),0.26455029224784055,0.7288509895126837,0.839766081871345,1.0,1.0,12/42,23.52%,NCBP2;CCNT2;MEPCE;RNPC3;RBM41;EFTUD2;DDX39B;SNRPB2;CDK9;SART3;SNRPD3;LSM4
prerank,metallocarboxypeptidase activity (GO:0004181),-0.22272151823564734,-0.7282227434814298,0.8857142857142857,1.0,1.0,6/26,15.92%,AGBL4;AGTPBP1;AGBL5;AGBL3;CPE;CPA6
prerank,microtubule motor activity (GO:0003777),0.258066854970017,0.727740957925853,0.86368843069874,1.0,1.0,6/51,9.37%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B
prerank,ribonuclease P activity (GO:0004526),-0.28208637662132524,-0.7269752958230885,0.8252427184466019,0.9989963309981703,1.0,7/11,30.30%,RPP38;RPP40;POP4;POP5;POP7;PRORP;POP1
prerank,mRNA methyltransferase activity (GO:0008174),0.3326700259821881,0.7267127339796711,0.7904903417533432,1.0,1.0,4/12,16.80%,TRMT61B;RNMT;TRMT10C;METTL14
prerank,nucleotidase activity (GO:0008252),0.3130113593682483,0.7258136261426031,0.7958904109589041,1.0,1.0,2/15,6.73%,NT5DC1;NT5C3A
prerank,phospholipase A2 activity (GO:0004623),0.2829252724102391,0.7255466812859793,0.8341584158415841,1.0,1.0,6/26,21.72%,PLA2G12A;ABHD3;PLA2G4E;PNPLA3;PLA2G6;PNPLA8
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.23361180196984055,-0.724634823044666,0.8754578754578755,0.993575858868122,1.0,8/19,29.98%,PAK2;AFAP1L2;CD24;EGF;NRG3;ABI1;DGKQ;GREM1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.30024822027528436,0.7243519650901614,0.8113456464379947,1.0,1.0,5/20,23.85%,SLC30A1;SLC30A5;SLC39A10;SLC39A3;SLC39A13
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.33355586331060977,0.7221562811386799,0.8049853372434017,1.0,1.0,4/11,20.11%,APLF;ALKBH1;NEIL2;HMCES
prerank,MAP-kinase scaffold activity (GO:0005078),0.33496221799575976,0.7220358082780909,0.8144927536231884,1.0,1.0,4/11,15.67%,MAPK8IP3;MAP2K2;AKAP13;SPAG9
prerank,glucose transmembrane transporter activity (GO:0005355),0.3073712653100656,0.7212977603473711,0.8245382585751979,1.0,1.0,1/17,4.16%,SLC2A6
prerank,high voltage-gated calcium channel activity (GO:0008331),0.33869028747716917,0.72005339042986,0.8078668683812406,1.0,1.0,1/10,8.39%,CACNA1A
prerank,phospholipase C activity (GO:0004629),0.28505623404870223,0.7191722251663051,0.8391248391248392,1.0,1.0,3/25,9.34%,PLCB4;CCL5;PLCB3
prerank,signal sequence binding (GO:0005048),0.2675026427098639,0.7167279087245325,0.8550185873605948,1.0,1.0,7/35,17.93%,RANBP6;NUP153;KPNB1;KDELR1;TNPO2;PEX5;BABAM2
prerank,phosphatase inhibitor activity (GO:0019212),0.28981113265403424,0.7152890670653743,0.8284182305630027,1.0,1.0,9/20,30.64%,ARPP19;PPME1;MGAT5;SET;CABIN1;ENSA;BOD1;PPP1R2;LGALS3
prerank,AMP binding (GO:0016208),0.3264321994178422,0.714948332639792,0.8249258160237388,0.9993920086144416,1.0,3/11,18.04%,PFKM;PRKAG1;ACSS2
prerank,neuropeptide binding (GO:0042923),0.2950557840186544,0.7143968027863499,0.8189300411522634,0.9978770395644284,1.0,2/18,11.56%,GPR37;SORL1
prerank,cAMP response element binding (GO:0035497),-0.28641334160705906,-0.7132698941443057,0.8338557993730408,0.9997998674707665,1.0,4/10,22.63%,ATF7;HMGA2;CREB1;ATF2
prerank,sulfotransferase activity (GO:0008146),0.26583383273280387,0.7129756847561368,0.8435619735258725,0.9973999602152729,1.0,1/33,0.26%,TPST1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.25164608014777695,0.7119353010332208,0.8668171557562077,0.9965832034153582,1.0,8/55,15.96%,TRPM2;CUL5;ITPR1;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,actin binding (GO:0003779),0.22682409881568324,0.7097663434445293,0.9380081300813008,0.9969621788030777,1.0,42/170,23.68%,MYOZ2;NOD2;CXCR4;UTRN;FLNB;PARVB;BCL7B;MRTFA;CCDC88A;SSH3;SPEF1;CORO7;FXYD5;CAPZB;GSN;MYRIP;SYNPO;TRPV4;PRKCE;MOBP;PLEKHH2;MYO6;RUSC1;DBNL;GAS2L3;PHACTR4;PDLIM3;TNNI2;MYH9;ABITRAM;MAP1B;MSRB1;KLHL1;ABL2;IQGAP2;NRAP;TWF1;FHL3;VASH1;ANG;PARVG;MAEA
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.2170910828740446,-0.7089979032039868,0.9163179916317992,0.9967131555261366,1.0,3/21,21.25%,CHRNA7;CHRFAM7A;CHRNA4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.2211599689197645,-0.7078502178756919,0.8884462151394422,0.9897610249278512,1.0,9/20,26.38%,MOGAT3;DGAT1;AGPAT4;AGPAT2;PLA2G15;GPAT4;GPAT3;DGAT2;LCLAT1
prerank,poly(A) binding (GO:0008143),0.2867237718192237,0.704115542762045,0.8595800524934383,1.0,1.0,10/21,29.44%,RBMS2;HNRNPDL;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC4;PABPC1
prerank,gated channel activity (GO:0022836),0.3135282390227866,0.7034452745936813,0.849493487698987,1.0,1.0,2/14,9.23%,TMC1;TMEM266
prerank,hexose transmembrane transporter activity (GO:0015149),0.3205625909928385,0.7032316971104852,0.8235294117647058,0.9982579823817991,1.0,1/12,4.16%,SLC2A6
prerank,MAP kinase activity (GO:0004707),0.3130793460384672,0.7010584404136547,0.8381344307270233,0.9986452105732238,1.0,2/14,9.57%,MAPK6;MAPK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.28310203194697575,0.700720592726587,0.8567674113009198,0.9948764129796672,1.0,10/21,27.30%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.28310203194697575,0.700720592726587,0.8567674113009198,0.9948764129796672,1.0,10/21,27.30%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,GABA receptor binding (GO:0050811),0.3195696970327525,0.700544006318592,0.8240469208211144,0.9930153181704271,1.0,2/11,12.78%,TRAK1;ARFGEF2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.27351421650521923,0.6992156423805649,0.8541666666666666,0.9925053730264887,1.0,3/25,12.31%,CH25H;CYP26B1;CYP27A1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.28795160553974447,0.6983377901772548,0.8495212038303693,0.9914839731887646,1.0,8/19,27.05%,GRIK3;GRID1;GABRG1;GRIK4;GABRA3;GRIK2;GRIK5;GABRG2
prerank,C-C chemokine receptor activity (GO:0016493),0.28597134780098415,0.6966082828955641,0.8682476943346509,0.9913132310438594,1.0,2/21,8.51%,CXCR4;ACKR3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.2851180428933555,0.6948322787855066,0.8596491228070176,0.991151573063599,1.0,5/20,14.33%,AK4;AK3;CMPK2;TJP2;DLG1
prerank,SH3 domain binding (GO:0017124),0.240004387822118,0.6919792271052724,0.9050772626931567,0.9922247464828178,1.0,7/62,10.72%,ZNF106;CNTNAP1;SYNJ1;CABYR;EVL;SH3BP2;DNM2
prerank,chloride channel activity (GO:0005254),0.2398304995486385,0.6919757305135135,0.9019165727170236,0.9902039731104618,1.0,18/59,27.05%,CLIC4;CLCN2;CLCN6;TTYH1;GLRA2;CLCN7;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;CLIC1;GABRA3;SLC26A7;CFTR;ANO4;ANO3;GABRG2
prerank,nucleotide diphosphatase activity (GO:0004551),-0.24854785861872236,-0.6903721810874006,0.8389513108614233,1.0,1.0,3/14,16.57%,FHIT;NUDT6;ENPP4
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2673432049150715,0.6898051249404639,0.8705128205128205,0.9903663892077224,1.0,3/27,6.96%,ITPR1;ASIC4;SLC11A2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.24893174282238598,0.688701866006305,0.8826291079812206,0.9894740621781539,1.0,5/46,11.67%,EXT1;GCNT4;B3GLCT;MGAT4C;B3GALNT1
prerank,3'-5' exonuclease activity (GO:0008408),0.2455119361916958,0.6841175759167364,0.9038686987104337,0.9921997295762037,1.0,4/45,4.86%,PNPT1;XRN2;APLF;CNOT7
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2507503822874323,0.6787251401797418,0.8841463414634146,0.9956163094297629,1.0,3/34,4.86%,PNPT1;XRN2;CNOT7
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2933011126647324,0.6783363873208997,0.8623595505617978,0.9939934575696457,1.0,2/15,9.00%,P2RY13;P2RX4
prerank,calcium-dependent phospholipid binding (GO:0005544),0.24382550217866014,0.6777933504852155,0.9170560747663551,0.9925070738861731,1.0,17/49,27.20%,CPNE3;SYT7;SYT3;RPH3A;ANXA4;PLA2G4E;MCTP1;CPNE9;ESYT2;C2CD5;PCLO;SYT12;SYT11;ANXA2;PLA2G4A;SYT4;ANXA9
prerank,chemokine receptor activity (GO:0004950),0.27165933233933603,0.6774417136948866,0.8761290322580645,0.9908537876235717,1.0,3/24,12.51%,CXCR4;ACKR3;GPR35
prerank,calcium:sodium antiporter activity (GO:0005432),0.3227504325245837,0.6773338379483925,0.8552238805970149,0.9889565518364551,1.0,2/10,15.96%,SLC8A1;SLC24A3
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3147428102474371,0.677131335439898,0.8472012102874432,0.9871673649977766,1.0,4/10,24.20%,USP15;IDE;DNAJB2;DNAJC2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.30531397692483886,0.676802360891114,0.8625525946704067,0.9854692124616183,1.0,2/13,9.07%,AGPAT5;LPCAT2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.31364282166037083,0.6755145781257411,0.866464339908953,0.9848150279659624,1.0,2/11,11.12%,SLC19A1;SLC25A25
prerank,syntaxin-1 binding (GO:0017075),-0.21848286160402863,-0.673361666278593,0.9012875536480687,1.0,1.0,6/22,20.13%,DAPK1;NSF;VAMP3;STXBP5;UNC13A;SYT1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.30562816457030784,0.6725010985323645,0.8372739916550765,0.9858791455718157,1.0,5/12,22.32%,CDK12;CDK19;CCNK;CDK9;CDK8
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3061030077124169,0.6714830486503648,0.8603945371775418,0.9849461114696388,1.0,4/12,26.79%,CNOT7;PAN3;NOCT;CNOT2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.3234068623876455,0.6713567499544161,0.8582554517133957,0.983109567650898,1.0,3/10,16.02%,RIOX2;KDM8;KDM7A
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.24453114167131182,-0.6695533084243516,0.9150326797385621,1.0,1.0,2/13,2.76%,SLC66A1;SLC7A2
prerank,actinin binding (GO:0042805),0.26664742189903057,0.66321611319877,0.8863636363636364,0.9890340591946118,1.0,2/21,6.30%,CSRP1;NFKB1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3165967567463988,0.6630916141040059,0.8721264367816092,0.9852495619725903,1.0,3/10,18.47%,DUSP10;DUSP16;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3165967567463988,0.6630916141040059,0.8721264367816092,0.9852495619725903,1.0,3/10,18.47%,DUSP10;DUSP16;DUSP8
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3004762347694096,0.6626292827838339,0.8622222222222222,0.9837530812268303,1.0,2/12,11.23%,CCDC88A;VEGFD
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.230988368972907,0.6620110479316206,0.9198218262806236,0.9823308076715905,1.0,11/57,19.72%,UQCRQ;NDUFA5;NDUFB9;NDUFS1;UQCR10;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,secondary active transmembrane transporter activity (GO:0015291),0.23647715791478358,0.661155683813985,0.945664739884393,0.9811969125989278,1.0,6/51,10.48%,SLCO1C1;SLC25A16;SLCO1B1;ANKH;SLC25A10;TMEM241
prerank,vitamin D receptor binding (GO:0042809),0.2871652871303575,0.6577738612259804,0.8725490196078431,0.9823474548830798,1.0,6/14,24.90%,MED12;SNW1;MED16;MED24;TAF7;TAF11
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3131743482678517,0.65302990316437,0.8753709198813057,0.9846822210713092,1.0,3/10,11.25%,ASH1L;SETD5;SETDB2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.2574331291559822,-0.6494867134636403,0.8672566371681416,1.0,1.0,3/10,17.83%,GALM;DSEL;GFUS
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.23800147330359606,0.645383911372294,0.927120669056153,0.989340807872114,1.0,10/38,23.89%,DENND1A;RUBCNL;ZFYVE26;KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;PLA2G4E;ZFYVE1;SNX12
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.2725529581938972,0.6452370806404265,0.8872077028885832,0.9856099352838646,1.0,3/16,16.31%,TTYH1;ANO10;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.2725529581938972,0.6452370806404265,0.8872077028885832,0.9856099352838646,1.0,3/16,16.31%,TTYH1;ANO10;ANO5
prerank,FMN binding (GO:0010181),0.2993507346162103,0.6448969609215798,0.8797564687975646,0.9839852981419317,1.0,3/11,23.82%,DUS2;PPCDC;NDOR1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.2367450027202379,-0.6383180516616499,0.9283276450511946,1.0,1.0,6/13,30.21%,IL1R1;ITGB3;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,leak channel activity (GO:0022840),-0.21245010257182922,-0.6380961748880739,0.9416342412451362,1.0,1.0,8/18,36.17%,NALCN;KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,histone deacetylase activity (GO:0004407),0.2624854072744346,0.6359950010587474,0.9189907038512616,0.9892324248560881,1.0,11/19,30.14%,SIRT6;MIER1;HDAC8;HDAC1;HDAC2;HDAC4;HDAC6;SIRT2;HDAC5;SIRT3;HDAC11
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3071500568945466,0.6357962930406686,0.8944281524926686,0.9874846355323609,1.0,2/10,16.78%,NAA50;KAT8
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.2803593695294909,0.6343919328636138,0.8926553672316384,0.9867191768457862,1.0,5/14,23.01%,TSEN2;RPP30;TSEN34;RPP14;RPP21
prerank,ribonuclease P RNA binding (GO:0033204),-0.251610165669766,-0.6321608080188522,0.912621359223301,1.0,1.0,6/10,30.30%,RPP38;RPP40;POP4;POP5;POP7;POP1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.24136624333047052,0.6313296242558313,0.9154746423927178,0.9872313492795621,1.0,2/27,6.36%,POLR2G;POLR3B
prerank,exoribonuclease activity (GO:0004532),0.28483101038452735,0.6308436098021196,0.9164265129682997,0.9856879082359234,1.0,3/12,14.09%,CNOT7;ZC3H12A;EXOSC9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.21732224229233676,0.6276649321788218,0.9463087248322147,0.9862510428270018,1.0,18/54,28.35%,ASAH2;SIRT6;NGLY1;MIER1;HDAC8;HINT3;ACER3;HDAC1;TGM2;NIT1;HDAC2;HDAC4;HDAC6;SIRT2;NTAN1;GLS2;KLK3;HDAC5
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.2654630704585037,0.6255644661515658,0.9088471849865952,0.9839878858008084,1.0,2/17,7.51%,EPHA4;EPHA6
prerank,ephrin receptor activity (GO:0005003),0.2654630704585037,0.6255644661515658,0.9088471849865952,0.9839878858008084,1.0,2/17,7.51%,EPHA4;EPHA6
prerank,alanine transmembrane transporter activity (GO:0022858),0.2824598932980959,0.6243104411804796,0.9104046242774566,0.9830819656679748,1.0,4/12,25.62%,SLC38A3;SLC36A4;SLC6A6;SLC36A1
prerank,phosphatidylglycerol binding (GO:1901611),0.2770694394852477,0.6219278581142155,0.9002849002849003,0.9829534692079966,1.0,1/13,3.61%,PLEKHN1
prerank,amino acid binding (GO:0016597),0.23523427506333539,0.6200896340286051,0.9371293001186239,0.9824450281144974,1.0,5/31,16.22%,AGXT;AARS1;GLRA2;SHMT1;GCLC
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.1962014839714893,-0.6191484089471406,0.9521739130434783,0.987985912633338,1.0,6/22,28.00%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,serotonin receptor activity (GO:0099589),-0.1962014839714893,-0.6191484089471406,0.9521739130434783,0.987985912633338,1.0,6/22,28.00%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.1962014839714893,-0.6191484089471406,0.9521739130434783,0.987985912633338,1.0,6/22,28.00%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.27899557406383096,0.6188801048044408,0.9033674963396779,0.9814541866964416,1.0,2/12,11.12%,SLC19A1;SLC25A25
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.23387882184396208,0.618638809832353,0.9263959390862944,0.9797825818375637,1.0,2/27,6.36%,POLR2G;POLR3B
prerank,phospholipid transfer activity (GO:0120014),0.25240326325752804,0.6168951751756855,0.928388746803069,0.9791865018005558,1.0,8/21,23.30%,PITPNM1;PLEKHA3;MTTP;OSBPL2;GLTP;TNFAIP8L3;CERT1;PITPNA
prerank,antiporter activity (GO:0015297),0.2541575886076469,0.6166977561354706,0.9264705882352942,0.9774811573245158,1.0,6/20,23.00%,SLC25A16;SLC25A10;TMEM241;SLC35D1;SLC35C2;SLC25A30
prerank,single-stranded telomeric DNA binding (GO:0043047),0.28748918820233405,0.6165346746425618,0.9096209912536443,0.9757341554492215,1.0,4/11,18.77%,HNRNPA2B1;HNRNPA1;STN1;TERF2
prerank,ephrin receptor binding (GO:0046875),0.24628283372744994,0.6058607155921181,0.9262295081967213,0.9808603609296489,1.0,4/21,15.54%,LYN;CHN1;FYN;CRK
prerank,voltage-gated anion channel activity (GO:0008308),0.2664410313292397,0.6048696726868854,0.9429763560500696,0.9796882352798396,1.0,2/15,5.86%,CLCN2;CLCN6
prerank,voltage-gated sodium channel activity (GO:0005248),-0.18338301508571708,-0.6003619992708256,0.9875,0.9908926035612992,1.0,9/22,31.82%,SCN3A;SCN3B;SCN9A;SCN7A;HCN3;SCN2B;CACNA1G;HCN4;CACNA1H
prerank,histone acetyltransferase activity (GO:0004402),0.22664327674969084,0.5962411226382749,0.9550970873786407,0.9831914024468874,1.0,12/30,28.53%,NAA50;KAT14;TADA2A;KAT8;KAT7;MCM3AP;KAT6A;KAT5;KAT2B;EP300;SRCAP;USP22
prerank,O-acyltransferase activity (GO:0008374),0.22328037593742742,0.5931010223822389,0.9501246882793017,0.9833189149994298,1.0,4/30,16.64%,PIGW;LPCAT2;SOAT2;SOAT1
prerank,adrenergic receptor binding (GO:0031690),0.2537224033235856,0.591835643418485,0.9410187667560321,0.9822592397215084,1.0,2/16,8.09%,MAGI2;RAPGEF2
prerank,store-operated calcium channel activity (GO:0015279),0.2740726368167586,0.5900602131042137,0.9351432880844646,0.9814753890227471,1.0,6/10,31.84%,TRPC4;TRPC1;ORAI1;TRPC7;STIM2;TRPC3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.27216325515068285,0.5796349795866983,0.9422222222222222,0.9855109823378387,1.0,1/10,5.09%,CDKN2D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.24813849658094625,0.5750521339684053,0.9611111111111111,0.9841025577650521,1.0,4/16,22.38%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.24813849658094625,0.5750521339684053,0.9611111111111111,0.9841025577650521,1.0,4/16,22.38%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2510237675857135,0.574047120005547,0.9443651925820257,0.9827888825768882,1.0,2/14,13.66%,USP15;MINDY3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.20620152518254317,-0.5638376049233477,0.9698996655518395,0.9985667142230761,1.0,4/13,17.86%,ARHGDIB;RGS14;GDI1;ITGB1BP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.256434400502197,0.5634297850802639,0.9415204678362573,0.985950275464416,1.0,12/12,74.38%,ELOVL4;OPN1SW;RHO;GNAT2;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,cAMP binding (GO:0030552),0.26715766079897524,0.5619644151552274,0.9391304347826087,0.9847715365275134,1.0,4/11,21.88%,RAPGEF2;PDE4B;CNBD2;PDE4A
prerank,serine-type peptidase activity (GO:0008236),0.18671412951635397,0.5599875795586493,0.9915164369034994,0.9838899157779333,1.0,8/96,15.82%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;PREP;MASP1;HTRA3
prerank,serine-type endopeptidase activity (GO:0004252),0.18807295435171484,0.5546926412916577,0.9913606911447084,0.9843472855276791,1.0,6/80,13.82%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;MASP1
prerank,phosphate ion binding (GO:0042301),-0.2230040402571546,-0.5439417317424357,0.9584569732937686,0.9975685124820672,1.0,1/10,5.54%,PNP
prerank,symporter activity (GO:0015293),0.255962842078835,0.5410609520104526,0.9535928143712575,0.9879352544717668,1.0,10/10,74.42%,SLC5A6;SLC4A4;SLC5A8;SLC28A3;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC28A2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.2546471636226844,0.5370403458647035,0.9649122807017544,0.9875902678178026,1.0,4/10,29.09%,CYLD;OTUD5;STAMBPL1;ATXN3
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19413649297382424,-0.5366750631047391,0.9679715302491103,0.9924517691628963,1.0,8/14,36.16%,CMPK1;DTYMK;NME1;NME2;AK7;AK9;NME4;AK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.25045942873551436,0.5350791683111162,0.9578313253012049,0.9864267297741383,1.0,3/10,19.73%,FEN1;DCLRE1A;DCLRE1C
prerank,organic cation transmembrane transporter activity (GO:0015101),0.21974681988787226,0.5158491761897329,0.9751724137931035,0.9903726087851982,1.0,15/16,62.77%,SLC44A1;SLC25A26;SLC22A4;SLC5A7;SLC22A5;SLC22A16;SLC44A4;SLC22A1;SLC7A8;SLC29A4;SLC22A2;SLC44A2;SLC22A3;SLC18A3;SLC25A17
prerank,phospholipase inhibitor activity (GO:0004859),-0.20938744259070277,-0.5150443054746964,0.9841269841269841,0.9900201471208359,1.0,4/10,32.17%,SNCA;ANXA1;APOC1;SNCB
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.22312373111642408,0.5030258574829932,0.981021897810219,0.9917738409933676,1.0,3/14,15.81%,CAPNS1;CAPN1;CAPN5
prerank,fibroblast growth factor receptor binding (GO:0005104),0.20027841100743335,0.5026530119982892,0.985969387755102,0.9900809214132998,1.0,3/21,22.01%,FGF9;NPTN;FGF2
prerank,phosphatidate phosphatase activity (GO:0008195),0.21182261106929226,0.467688577177872,0.9970674486803519,0.9946813341848872,1.0,5/13,25.40%,LPIN2;PLPP2;PLPPR2;PLPPR1;PLPP1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2041323852824859,0.46015556220288883,0.9914040114613181,0.9938644642992325,1.0,2/13,17.75%,IDI1;EBP
